Secondary Schizophrenia


Secondary Schizophrenia

Schizophrenia may not be a single disease, but the result of a diverse set of related conditions. Modern neuroscience is beginning to reveal some of the genetic and environmental underpinnings of schizophrenia; however, an approach less well travelled is to examine the medical disorders that produce symptoms resembling schizophrenia. This book is the first major attempt to bring together the diseases that produce what has been termed 'secondary schizophrenia'. International experts from diverse backgrounds ask the questions: does this medical disorder, or drug, or condition cause psychosis? If yes, does it resemble schizophrenia? What mechanisms form the basis of this relationship? What implications does this understanding have for aetiology and treatment? The answers are a feast for clinicians and researchers of psychosis and schizophrenia. They mark the next step in trying to meet the most important challenge to modern neuroscience – understanding and conquering this most mysterious of human diseases.


 Reviews:

' … this book provides a rich and comprehensive review of the many conditions know n to be associated with psychosis, which could be of great value to students and a resource for senior scientists in the field. it is thought-provoking and its treatments of provocative issues resulting from very recent research are timely and enjoyable. The book is particularly satisfying because it excels on so many levels. This includes the clear list-making organization of basic facts characteristic of the allopathic tradition, and the thoughtful attempt at integration of disparate findings into etiopathogenic explanations of signs and symptoms. Adding to this already very useful review of vast swathes of clinically oriented literature is the valiant and nuanced contextualization of otherwise typical textbook fare into the fundamental conceptual conundrm lurking at the heart of the entire book: what is schizophrenia.' The Journal of Psychological Medicine

Östling S. , Skoog I. Psychotic symptoms and paranoid ideation in a non-demented population-based sample in the very old. Arch Gen Psychiatry, 2002. 59:53–9.
Physicians' Desk Reference. Montvale, NJ: Medical Economics, 1999.
Aarsland D. , Larsen J. P. , Cummings J. L. , et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease. Arch Neurol, 1999. 56:595–601.
Aarsland D. , Litvan I. , Larsen J. P. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsych Clin Neurosci, 2001. 13(1):42–9.
Abbas A. , Styra R. Valproate prophylaxis against steroid induced psychosis. Can J Psychiatry, 1994. 39:188–9.
Abbott E. J. , Connor G. B. , Artes P. H. , et al. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet Syndrome). Invest Ophthalmol Vis Sci, 2007. 48(3):1416–23.
Abdolmaleky H. M. , Faraone S. V. , Glatt S. J. , et al. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res, 2004. 67:53–62.
Abdul-Monim Z. , Neill J. C. , Reynolds G. P. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol, 2007. 21(2):198–205.
Abe K. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology, 2004. 63(12):2458.
Abecasis G. R. , Burt R. A. , Hall D. , et al. Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1. Am J Hum Genet, 2004. 74:403–17.
Abel K. M. , Allin M. P. G. , Hemsley D. R. , et al. Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacology, 2003. 44(6):729–37.
Abi-Dargham A. , Gil R. , Krystal J. , et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry, 1998. 155:761–7.
Abi-Dargham A. Alterations of serotonin transmission in schizophrenia. Int Rev Neurobiol, 2007. 78:133–64.
AbiDargham A. , Laruelle M. , Charney D. , et al. Serotonin and schizophrenia: a review. Drugs Today, 1996. 32(2):171–85.
Abraham H. , Aldridge A. , Gogia P. The psychopharmacology of hallucinogens. Psychopharmacology, 1996. 14:285–98.
Abraham H. D. , Aldridge A. M. , Gogia P. The psychopharmacology of hallucinogens. Neuropsychopharmacology, 1996. 14(4):285–98.
Abraham H. D. , Aldridge A. M. Adverse consequences of lysergic-acid diethylamide. Addiction, 1993. 88(10):1327–34.
Abrams R. , Taylor M. Catatonia: a prospective clinical study. Arch Gen Psychiatry, 1976. 33:579–81.
Acharya V. , Acharya J. , Luders H. Olfactory epileptic auras. Neurology, 1998. 51(1):56–61.
Achim A. M. , Bertrand M. C. , Sutton H. , et al. Selective abnormal modulation of hippocampal activity during memory formation in first-episode psychosis. Arch Gen Psychiatry, 2007. 64:999–1014.
Achte K. , Hillbom E. , Aalberg V. Psychoses following war injury. Acta Psychiatr Scand, 1969. 45:1–18.
Adachi M. , Wellmann K. F. , Volk B. W. Histochemical studies on the pathogenesis of “idiopathic non-arteriosclerotic cerebral calcification.” J Neuropathol Exper Neurol, 1968. 27(1):153–4.
Adachi N. , Kato M. , Sekimoto M. , et al. Recurrent postictal psychosis after remission of interictal psychosis: further evidence of bimodal psychosis. Epilepsia, 2003. 44: 1218–22.
Adachi N. , Onuma T. , Nishiwaki S. , et al. Inter-ictal and post-ictal psychoses in frontal lobe epilepsy: a retrospective comparison with psychoses in temporal lobe epilepsy. Seizure, 2000. 9:328–35.
Adair D. , Keshavan M. The Charles Bonnet Syndrome and grief reaction. Am J Psychiatry, 1988. 145:895.
Adams B. , Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci, 1998. 18(14):5545–54.
Adams R. D. , Fisher C. M. , Hakim S. , et al. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure a treatable syndrome. New Engl J Med, 1965. 273:117–26.
Addington J. , Saeedi H. , Addington D. Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. Br J Psychiatry, 2006. 189:373–8.
Adelstein L. , Carter M. Psychosis: its importance as a presenting symptom of brain tumour. Am J Psychiatry, 1932. 12:317–29.
Adityanjee Schulz S. C. Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry, 2002. 63(Suppl 13):32–8.
Adler C. M. , Goldberg T. E. , Malhotra A. K. , et al. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry, 1998. 43(11):811–16.
Adler L. E. , Olincy A. , Cawthra R. N. , et al. Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology, 2001. 24(6):671–9.
Adler L. E. , Pachtman E. , Franks R. D. , et al. Neurophysiological evidence for a deficit in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry, 1982. 17:639–54.
Adolphs R. , Baron-Cohen S. , Tranel D. Impaired recognition of social emotions following amygdala damage. J Cogn Neurosci, 2002. 14(8):1264–74.
Afifi A. K. , Menezes A. H. , Reed L. A. , et al. Atypical presentation of X-linked adrenoleukodystrophy with an unusual magnetic resonance imaging pattern. J Child Neurol, 1996. 11:497–9.
Aghajanian G. , Marek G. Serotonin and hallucinogens. Neuropsychopharmacology, 1999. 21:S16–S23.
Aghajanian G. K. , Marek G. J. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Rev, 2000. 31(2–3):302–12.
Agid Y. , Buzsaki G. , Diamond D. M. , et al. Viewpoint – How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov, 2007. 6(3):189–201.
Ahmad M. , Rasul F. M. Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease. Am J Emerg Med, 1999. 17:735.
Ahmad S. , Fowler L. J. , Whitton P. S. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res, 2005. 63(2–3):141–9.
Ahn M. S. , Sims K. B. , Frazier J. A. Risperidone-induced psychosis and depression in a child with a mitochondrial disorder. J Child Adolesc Psychopharmacol, 2005. 15:520–5.
Akanuma N. , Kanemoto K. , Adachi N. , et al. Prolonged postictal psychosis with forced normalization (Landolt) in temporal lobe epilepsy. Epilepsy Behav, 2005. 6:456–9.
Akanuma N. , Kanemoto K. , Adachi N. , et al. Prolonged postictal psychosis with forced normalization (Landolt) in temporal lobe epilepsy. Epilepsy Behav, 2005. 6:456–9.
Akbarian S. , et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry, 1993. 50(3):169–77.
Akbarian S. , Bunney JE Jr. , Potkin SG. , et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate- diaphorase cells in frontal lobe of schizophrenia implies disturbance of cortical development. Arch Gen Psychiatry, 1993. 50:169–77.
Akey J. , Jin L. , Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet, 2001. 9:291–300.
Akil M. , Brewer G. J. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol, 1995. 65:171–8.
Akil M. , Brewer G. J. Psychiatric and behavioral abnormalities in Wilson's disease. Adv Neurol, 1995. 65:171–8.
Akil M. , Schwartz J. A. , Dutchak D. , et al. The psychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci, 1991. 3:377–82.
Aksoy S. , Klener J. , Weinshilboum R. M. Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and western blot analysis of human liver samples. Pharmacogenetics, 1993. 3:116–22.
Alao A. O. , Naprawa S. A. Psychiatric complications of hydrocephalus. Intl J Psychiatry Med, 2001. 31(3):337–40.
Alee A. , Knesevich M. Schizophrenia-like psychosis associated with vein of Galen malformation: a case report. Canad J Psychiatry, 1987. 32:226–7.
Aleman A. , et al. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry, 1999. 156(9):1358–66.
Aleman A. , et al. Mental imagery and perception in hallucinationprone individuals. J Nerv Ment Dis, 2000. 188:830–6.
Aleman A. , Kahn R. S. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol, 2005. 77(5):283–98.
Alexopoulos G. S. , Jeste D. V. , Chung H. , et al. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Postgrad Med, 2005. Spec No:6–22.
Alldredge B. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology, 1999. 53(Suppl 2): S68–S75.
Allebeck P. (1991). Cannabis and schizophrenia: is there a causal association?. In Physiopathology of Illicit Drugs: Cannabis, Cocaine, Opiates, Nahas G. and Latour C. (Eds.). Oxford: Pergamon Press.
Allebeck P. , Varla A. , Kristjansson E. , Wistedt B. Risk factors for suicide among patients with schizophrenia. Acta Psychiatr Scand, 1987. 76:414–19.
Allen D. N. , Goldstein G. , Forman S. D. , et al. Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism. Neuropsychiatry Neuropsychol Behav Neurol, 2000. 13:184–7.
Allen P. , Amaro E. , Fu C. H. , et al. Neural correlates of the misattribution of speech in schizophrenia. Br J Psychiatry, 2007. 190:162–9.
Allen R. M. , Young S. J. Phencyclidine-induced psychosis. Am J Psychiatry, 1978. 135(9):1081–4.
Allodi F. Acute paranoid reaction (bouffee delirante) in Canada. Can J Psychiatry, 1982. 27:366–73.
Almeida O. P. , Xiao J. Morbidity and mortality associated with incident mental health disorders after stroke: results from a population-based record linkage study. Aust N Z J Psychiatry, 2007. 41:274–81.
Alroe C. J. , McIntyre J. N. M. Visual hallucinations. The Charles Bonnet syndrome and bereavement. Med J Aust, 1983. 2:674–5.
Altar C. A. , Jurata L. W. , Charles V. , et al. Deficient hippocampal Neuron, expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry, 2005. 58:85–96.
Altmuller J. , Palmer L. J. , Fischer G. , et al. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet, 2001. 69:936–50.
Alvarez L. M. , Castillo S. T. , Perez Z. J. A. , et al. Activity of aryl sulfatase A enzyme in patients with schizophrenic disorders. [English translation]. Rev Invest Clin, 1995. 47:387–92.
Alves D. , Pires M. M. , Guimaraes A. , et al. Four cases of late onset metachromatic leucodystrophy in a family: clinical, biochemical and neuropathological studies. J Neurol Neurosurg Psychiatry, 1986. 49:1417–22.
Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr, 1907. 64:146–8.
Amargos-Bosch M. , Lopez-Gil X. , Artigas F. , et al. Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine. Intl J Neuropsychopharmacol, 2006. 9(5):565–73.
Amemiya S. , Hamamoto M. , Goto Y. , et al. Psychosis and progressing dementia: presenting features of a mitochondriopathy. Neurology, 2000. 55(4):600–1.
American Hospital Formulary Service . Drug Information. Bethesda, Maryland: American Society of Hospital Pharmacists. 1995.
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders. IV Ed. Washington, DC: APA.
Anand A. , Charney D. S. , Oren D. A. , et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine – support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry, 2000. 57(3):270–6.
Anderson S. W. , Rizzo M. Hallucinations following occipital lobe damage: the pathological activation of visual representations. J Clin Exp Neuropsychol, 1994. 16:651–63.
Andreasen N. C. , Nopoulos P. , O'Leary D. S. , et al. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry, 1999. 46:908–20.
Andreasen N. C. , Nopoulos P. , O'Leary D. S. , et al. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry, 1999. 46:908–20.
Andreasen N. C. , O'Leary D. S. , Flaum M. , et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet, 1997. 349:1730–4.
Andreasen N. C. , Paradiso S. , O'Leary D. S. “Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical–subcortical–cerebellar circuitry? Schizophr Bull, 1998. 24:203–18.
Andreasen N. C. , Rezai K. , Alliger R. , et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry, 1992. 49:943–58.
Andreasen N. C. A unitary model of schizophrenia: Bleuler's “fragmented phrene” as schizencephaly. Arch Gen Psychiatry, 1999. 56:781–7.
Andreasson S. , et al. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet, 1987. 2:1483–6.
Anglin R. , Mazurek M. F. , Noseworthy M. , et al. The psychiatric profile of mitochondrial disorders: clinical presentation and MR spectroscopy findings. Society for Neuroscience Annual Meeting, San Diego, November 2007.
Anglin R. E. , Rosebush P. I. , Mazurek M. F. The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenon. J Neuropsychiatr Clin Neurosci, 2006. 18:450–9.
Angrist B. (1983). Psychoses induced by central nervous system stimulants and related drugs. In Stimulants: Neurochemical, Behavioral and Clinical Perspectives, Creese I. (Ed.). New York: Raven Press.
Angrist B. , et al. Amphetamine psychosis: behavioural and biochemical aspects. J Psychiatr Res., 1974. 11:13–23.
Angrist B. M. , Gershon S. The phenomenology of experimentally induced amphetamine psychosis – preliminary observations. Biol Psychiatry, 1970. 2:95–107.
Angrist B. M. , Gershon S. The phenomenology of experimentally induced amphetamine psychosis– preliminary observations. Biol Psychiatry, 1970. 2(2):95–107.
Angus B. , de Silva R. , Davidson R. , et al. A family with adult-onset cerebral adrenoleucodystrophy. J Neurol, 1994. 241:497–9.
Angyal A. , Sherman M. Postural reactions to vestibular stimulation in schizophrenic and normal subjects. Am J Psychiatry, 1942. 98:857–62.
Annegers J. F. , Grabow J. D. , Groover R. V. , et al. Seizures after head trauma: a population study. Neurology, 1908. 30:683–9.
Anthony J. , Helzer J. (1991). Syndromes of drug abuse and dependence. In Psychiatric Disorders in America, Robins L. and Regier D. (Eds.). New York: Free Press, Macmillan.
Anton E. S. , Marchionni M. A. , Lee K. F. , et al. Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex. Development, 1997. 124(18):3501–10.
Antonova E. , et al. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res, 2004. 70(2–3):117–45.
Antshel K. M. , Conchelos J. , Lanzetta G. , et al. Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome). Psychiatry Res, 2005. 138:235–45.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders. Fourth ed. Washington, DC: American Psychiatric Association.
APA Task Force on Nomenclature and Classification . (1987). DSM-III-R. Washington, DC: APA Press.
APA Task Force on Nomenclature and Classification . (1994). DSM-IV. Washington, DC: APA Press.
Apostolova L. G. , White M. , Moore S. A. , et al. Deep white matter pathologic features in watershed regions: a novel of central nervous system involvement in MELAS. Arch Neurol, 2005. 62:1154–6.
Apostolova L. G. , White M. , Moore S. A. , et al. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol, 2005. 62(7):1154–6.
Ara J. , Mayayo E. , Marzo M. , et al. Neurological impairment in alpha mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst, 1999. 15:369–71.
Araki T. , Ohba H. , Monzawa S. , et al. Membranous lipodystrophy: MR imaging appearance of the brain. Radiology, 1991. 180:793–7.
Arango C. , Bartko J. J. , Gold J. M. , et al. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry, 1999. 156:1349–57.
Arendt G. , Hefter H. , Stremmel W. , et al. The diagnostic value of multi-modality evoked potentials in Wilson's disease. Electromyogr Clin Neurophysiol, 1994. 34:137–48.
Arinami T. , Ohtsuki T. , Takase K. , et al. Screening for 22q11 deletions in a schizophrenia population. Schizophr Res, 2001. 52:167–70.
Arnold P. D. , Siegel-Bartelt J. , Cytrynbaum C. , et al. Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. Am J Med Genet, 2001. 105:354–62.
Arseneault L. , et al. Mental disorders and violence in total birth cohort: results from the Dunedin study. Arch Gen Psychiatry, 2000. 57(10):979–86.
Arseneault L. , Cannon M. , Poulton R. , et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J, 2002. 325:1212–13.
Arseneault L. , Cannon M. , Poulton R. , et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br Med J, 2002. 325:1212–3.
Arseneault L. , Cannon M. , Witton J. , Murray R. M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry, 2004. 184:110–17.
Arseneault L. , Moffitt T. E. , Caspi A. , Taylor P. J. , Silva P. A. Mental disorders and violence in a total birth cohort: results from the Dunedin Study. Arch Gen Psychiatry, 2000. 57:979–86.
Asaad G. , Shapiro B. Hallucinations: theoretical and clinical overview. Am J Psychiatry, 1986. 143:1088–97.
Ashwin P. T. , Tsaloumas M. D. Complex visual hallucinations (Charles Bonnet syndrome) in the hemianopic visual field following occipital infarction. J Neurol Sci, 2007. 263:184–6.
Askevold F. The occurrence of paranoid incidents and abstinence delirium in abusers of amphetamine. Acta Psychiatr Scand, 1959. 34:145–64.
Assal F. , Alacon M. , Solomon E. C. , et al. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol, 2004. 61(8):1249–53.
Atta-ur-Rahman, Harvey K. , Siddiqui R. A. Interleukin-8: an autocrine inflammatory mediator. Curr Pharm Des, 1999. 5(4):241–53.
Au Eong K-G. , Fujii G. Y. , Ng E. W. M. , et al. Transient formed visual hallucinations following macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol, 2001. 131: 664–6.
Aubourg P. , Mosser J. , Douar A. M. , et al. Adrenoleukodystrophy gene: unexpected homology to a protein involved in peroxisome biogenesis. Biochimie 1993. 75:293–302.
Augustine A. , Fricchione G. , Wiznicki R. , et al. Adult neuronal ceroid lipofuscinosis presenting with psychiatric symptoms: a case report. Int J Psychiatr Med, 1993. 23:315–22.
Austin C. P. , Ky B. , Ma L. , et al. Expression of Disrupted-In- Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development. NeuroScience, 2004. 124:3–10.
Austin C. P. , Ma L. , Ky B. , et al. DISC1 (Disrupted in Schizophrenia-1) is expressed in limbic regions of the primate brain. Neuroreport, 2003. 14:951–4.
Austin J. , Armstrong D. , Fouch S. , et al. Metachromatic leukodystrophy (MLD). VIII. MLD in adults; diagnosis and pathogenesis. Arch Neurol, 1968. 18:225–40.
Austin J. H. Studies in metachromatic leukodystrophy XI. Therapeutic considerations, 1972. Birth Defects: Original Article Series, 1973. 9:125–9.
Australian Institute of Health and Welfare . (2002). 2001 National Drug Strategy Household Survey; First Results. AIHW cat. no. PHE 35. Canberra: AIHW.
Australian Institute of Health and Welfare . (2005). 2004 National Drug Strategy Household Survey: Detailed Findings. AIHW cat. no. PHE 66. Canberra: AIHW.
Avrahami E. , Cohn D. F. , Feibel M. , et al. MRI demonstration and CT correlation of the brain in patients with idiopathic intracerebral calcification. J Neurol, 1994. 241(6):381–4.
Avramopoulos D. , Stefanis N. C. , Hantoumi I. , et al. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry, 2002. 7:706–11.
Baba A. , Hamada H. Musical hallucinations in schizophrenia. Psychopathology, 1999. 32(5):242–51.
Babb T. L. , Brown W. J. Neuronal, dendritic, and vascular profiles of human temporal lobe epilepsy correlated with cellular physiology in vivo. Adv Neurol, 1986. 44:949–66.
Babb T. L. , Kupfer W. R. , Pretorius J. K. Synaptic reorganization of mossy fibers into molecular layer in human epileptic fascia dentata. Abstracts of the Society for Neuroscience, 1988. 88:351.
Babbitt D. P. , Tang T. , Dobbs J. , et al. Idiopathic familial cerebrovascular ferrocalcinosis (Fahr's disease) and review of differential diagnosis of intracranial calcification in children. Am J Roentgenol Radium Ther Nucl Med, 1969. 105(2):352–8.
Babcock M. , DeSilva D. , Oaks R. , et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science, 1997. 276:1709–12.
Babulas V. , Factor-Litvak P. , Goetz R. , Schaefer C. A. , Brown A. S. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry, 2006. 163(5):927–9.
Bacanu S-A. , Devlin B. , Chowdari K. V. , et al. Heritability of psychosis in Alzheimer disease. Am J Geriatr Psychiatry, 2005. 13:624–7.
Bacanu S-A. , Devlin B. , Chowdari K. V. , et al. Linkage analysis of Alzheimer disease with psychosis. Neurology, 2002. 59(1):118–20.
Bacanu S. A. Robust estimation of critical values for genome scans to detect linkage. Genet Epidemiol, 2005. 28:24–32.
Bachmann S. , Bottmer C. , Schroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry, 2005. 162:2337–43.
Backman M. , Santavuori P. , Aberg L. , et al. Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis. J Intell Dis Res, 2005. 49:25–32.
Badner J. A. , Gershon E. S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry, 2002. 7:405–11.
Bae C. J. , Pincus J. H. Neurologic signs predict periventricular white matter lesions on MRI. Can J Neurol Sci, 2004. 31:242–7.
Baethge C. , et al. Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord, 2005. 7:136–45.
Bagalkote H. Maternal influenza and schizophrenia in the offspring. Int J Ment Health, 2001. 29(4):3–21.
Bagorda F. , Teuchert-Noodt G. , Lehmann K. . Isolation rearing or methamphetamine traumatisation induce a “disconnection” of prefrontal efferents in gerbils: implications for schizophrenia. J Neural Transm, 2006. 113:365–79.
Baguley D.M. Hyperacusis. J R Soc Med, 2003. 96(12):582–5.
Baily P. , Green J. R. , Amador L. , et al. Treatment of psychomotor states by temporal lobectomy: a report of progress. Res Publ Assoc Res Nerv Ment Dis, 1953. 31:341–6.
Baker A. , Bucci S. , Lewin T. J. , et al. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry, 2006. 188:439–48.
Baker A. , Lewin T. , Reichler H. , et al. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction, 2002. 97:1329–37.
Baker A. , Lewin T. , Reichler H. , et al. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatr Scand, 2002. 106:233–40.
Baker K. , Baldeweg T. , Sivagnanasundaram S. , et al. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry, 2005. 58:23–31.
Baker K. D. , Skuse D. H. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry, 2005. 186:115–20.
Bakker C. B. , Amini F. B. Observations on the psychotomimetic effects of Sernyl. Compr Psychiatry, 1961. 2:269–80.
Bakker C. B. , Amini F. B. Observations on the psychotomimetic effects of sernyl. Compr Psychiatry, 1961. 2:269–80.
Baldeweg T. , Spence S. , Hirsch S. R. , et al. Gamma-band electroencephalographic oscillations in a patient with somatic hallucinations. Lancet, 1998. 352:620–1.
Balk D. Adolescents' grief reactions and self-concept perceptions following sibling death: a study of 33 teenagers. J Youth Adolesc, 1983. 12:137–61.
Balla A. , Sershen H. , Serra M. , Koneru R. , Javitt D. C. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology, 2003. 28(1):34–44.
Ballard C. , Bennister C. , Graham C. , et al. Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry, 1995a. 167:537–40.
Ballard C. , Holmes C. , McKeith I. , et al. Psychiatric morbidity in dementia with -Lewy bodies: a prospective clinical and neuropathological comparison study with Alzheimer's disease. Am J Psychiatry, 1999. 156:1039–45.
Ballard C. , Neill D. , O'Brien J. , et al. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord, 2000. 59(2):97–106.
Ballard C. , Neill D. , O'Brien J. , et al. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord, 2000. 59:97–106.
Ballard C. , O'Brien J. T. (2002). Behavioural and psychological symptoms. In: Vascular Cognitive Impairment. Erkinjuntti T. and Gautheir S. (Eds.). London: Martin Dunitz, pp. 237–51.
Ballard C. , Saad K. , Patel A. , et al. The prevalence and phenomenology of psychotic symptoms in dementia sufferers. Int J Geriatr Psychiatry, 1995b. 10:477–85.
Ballard C. , Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Reviews, 2006. CD003476.
Ban S. , Mori N. , Saito K. , et al. An autopsy case of mitochondrial encephalomyopathy (MELAS) with special reference to extra-neuromuscular abnormalities. Acta Pathol Jpn, 1992. 42:818–25.
Ban T. A. , Lohrenz J. J. , Lehmann H. E. Observations on the action of sernyl – a new psychotropic drug. Can Psychiatr Assoc J., 1961. 6(3):150–7.
Bar K.-J. , et al. Transient activation of a somatosensory area in painful hallucinations shown by fMRI. Neuroreport, 2002. 13:1–4.
Barch D. M. , Csernansky J. G. Abnormal parietal cortex activation during working memory in schizophrenia: verbal phonological coding disturbances versus domain-general executive dysfunction. Am J Psychiatry, 2007. 164:1090–8.
Barnea-Goraly N. , Menon V. , Krasnow B. , et al. Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study. Am J Psychiatry, 2003. 160:1863–9.
Barnes J. , David A. S. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry, 2001. 70:727–33.
Barnes J. , David A. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry, 2001. 70:727–33.
Barnes T. R. , Mutsatsa S. H. , Hutton S. B. , Watt H. C. , Joyce E. M. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry, 2006. 188:237–42.
Barnes, T. R. , Mutsatsa S. H. , Hutton S. B. , Watt H. C. , Joyce E. M. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry, 2006. 188:237–42.
Barr A. M. , Panenka W. J. , MacEwan G. W. , et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci, 2006. 31(5):301–13.
Barr W. B. , Ashtari M. , Bilder R. M. , et al. Brain morphometric comparison of first-episode schizophrenia and temporal lobe epilepsy. Br J Psychiatry, 1997. 170:515–9.
Barragan-Campos H. M. , Vallee J. N. , Lo D. , Barrera-Ramirez C. F. , et al. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol, 2005. 62:737–42.
Barrett J. C. , Fry B. , Maller J. , et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 2005. 21:263–5.
Barrientos A. , Volpini V. , Casademont J. , et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest, 1996. 97(7):1570–6.
Barrowclough C. , Haddock G. , Tarrier N. , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry, 2001. 158:1706–13.
Bartels P. , Subach J. (1976). Significance probability mappings and automated interpretation of complex pictorial scenes. In Digital Processing of Biomedical Imagery, Preston E. and Onoe M. (Eds.). New York: Academic Press, pp. 101–14.
Bartlett E. , Hallin A. , Chapman B. , Angrist B. Selective sensitisation to the psychosis inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology, 1997. 16(1):77–82.
Bartlett E. , Hallin A. , Chapman B. , Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology, 1997. 16:77–82.
Bartlett M. The sensory acuity of psychopathic individuals: a comparison of the auditory acuity of psychoneurotic and dementia praecox cases with that of normal individuals. Psychiatr Q, 1935. 9:422–5.
Bartolucci G. , Younger J. Tentative classification of neuropsychiatric disturbances in Prader-Willi syndrome. J Intellect DisabiliRes, 1994. 38:621–9.
Bartos M. , Vida I. , Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci, 2007. 8(1):45–56.
Bartzokis G. , Beckson M. , Wirshing D. A. , et al. Choreoathetoid movements in cocaine dependence. Biol Psychiatry, 1999. 45:1630–5.
Bartzokis G. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology, 2002. 27:672–83.
Basar-Eroglu C. , Brand A. , Hildebrandt H. , et al. Working memory related gamma oscillations in schizophrenia patients. Intl J Psychophysiol, 2007. 64(1):39–45.
Basset A. S. , Honer W. G. Evidence for anticipation in schizophrenia. Am J Hum Genet, 1994. 54:864–70.
Bassett A. S. , Caluseriu O. , Weksberg R. , et al. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry, 2007. 61:1135–40. [Epub Jan 9, 2007.]
Bassett A. S. , Chow E. W. , AbdelMalik P. , et al. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry, 2003. 160:1580–6.
Bassett A. S. , Chow E. W. , Husted J. , et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A, 2005. 138:307–13.
Bassett A. S. , Chow E. W. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry, 1999. 46:882–91.
Bassett A. S. , Chow E. W. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry, 1999. 46:882–91.
Bassett A. S. , Hodgkinson K. , Chow E. W. , et al. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet, 1998. 81:328–37.
Bassiony M. , Lyketsos C. Delusions and hallucinations in Alzheimer's disease: review of the brain decade. Psychosomatics, 2003. 44:388–401.
Bassiony M. M. , Steinberg M. S. , Warren A. , et al. Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates. Int J Geriatr Psychiatry, 2000. 15:99–107.
Bassiony M. M. , Warren A. , Rosenblatt A. , et al. Isolated hallucinosis in Alzheimer's disease is associated with African-American race. Int J Geriatr Psychiatry, 2002b. 17:205–10.
Bassiony M. M. , Warren A. , Rosenblatt A. , et al. The relationship between delusions and depression in Alzheimer's disease. Int J Geriatr Psychiatry, 2002a. 17:549–56.
Bates A. T. , Liddle P. F. , Kiehl K. A. , et al. State dependent changes in error monitoring in schizophrenia. J Psychiatr Res, 2004. 38:347–56.
Battaglia J. , Lindborg S. R. , Alaka K. , et al. Calming versus sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med, 2003. 21:192–8.
Battisti C. , Tarugi P. , Dotti M. , et al. Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging, and molecular genetic study. Mov Disord, 2003. 18:1405–9.
Bauer L. O. Resting hand tremor in abstinent cocaine-dependent, alcohol-dependent, and polydrug-dependent patients. Alcohol Clin Exp Res, 1996. 20:1196–201.
Baumann N. , Masson M. , Carreau V. , et al. Adult forms of metachromatic leukodystrophy: clinical and biochemical approach. Dev Neurosci, 1991. 13:211–15.
Baumann N. , Turpin J. C. , Lefevre M. , et al. Motor and psychocognitive clinical types in adult metachromatic leukodystrophy: genotype/phenotype relationships? J Physiol Paris, 2002. 96:301–6.
Baumgartner C. , Podreka I. , Benda N. , et al. Postictal psychosis: a SPECT study (abstract). Epilepsia, 1995. 36(Suppl 3):S218.
Bayever E. , Ladisch S. , Philippart M. , et al. Bone-marrow transplantation for metachromatic leucodystrophy. Lancet, 1985. 2:471–3.
Beall S. S. , Patten B. M. , Mallette L. , et al. Abnormal systemic metabolism of iron, porphyrin, and calcium in Fahr's syndrome. Ann Neurol, 1989. 26(4):569–75.
Beard A. W. The association of hepatolenticular degeneration with schizophrenia. Acta Psychiatr Neurol Scand, 1959. 34:411–28.
Bearden C. E. , Jawad A. F. , Lynch D. R. , et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry, 2004a. 161:1700–2.
Bearden C. E. , van Erp T. G. , Dutton R. A. , et al. Mapping cortical thickness in children with 22q11.2 deletions. Cereb Cortex, 2007. 17:1889–98. [Epub Oct 20, 2006.]
Bearden C. E. , van Erp T. G. , Monterosso J. R. , et al. Regional brain abnormalities in 22q11.2 deletion syndrome: association with cognitive abilities and behavioral symptoms. Neurocase, 2004b. 10:198–206.
Beardsmore A. , Dorman T. , Cooper S-A. , et al. Affective psychosis and Prader-Willi syndrome. J Intellect Disabil Res, 1998. 42:463–71.
Beasley C. M. Jr. , Hamilton S. H. , Crawford A. M. , et al. Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial. Eur Neuropsychopharmacol, 1997. 7:125–37.
Beaumont J. G. , Dimond S. J. Brain disconnection and schizophrenia. Br J Psychiatry, 1973. 123:661–2.
Bechdolf A. , Pohlman B. , Geyer C. , et al. Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: A review. Fortsch Neurol Psychiatr, 2005. 73:728–35.
Beckman K. B. , Abel K. J. , Braun A. , et al. Using DNA pools for genotyping trios. Nucleic Acids Res, 2006. 34:e129.
Beckmann H. , Franzek E. , Stober G. Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet, 1996. 67:289–300.
Beckson M. , Cummings J. L. Psychosis in basal ganglia disorders. Neuropsychiatry Neuropsychol Behav Neurol, 1992. 5:126–31.
Begré S. , Koenig T. Cerebral disconnectivity: an early event in schizophrenia. Neuroscientist, 2008. 14:19–45.
Behrens M. M. , Ali S. S. , Dao D. N. , et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science, 2007. 318(5856):1645–7.
Bell D. S. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry, 1965. 111:701–7.
Bell D. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry, 1973. 29:35–40.
Bell J. , Carmichael E. A. On hereditary ataxia and spastic paraplegia. The Treasury of Human Inheritance, 1939. 4:141–281.
Bellack A. , Bennett M. E. , Gearon J. S. , et al. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry, 2006. 63:426–32.
Bellack A. S. Skills training for people with severe mental illness. Psychiatr Rehabil J, 2004. 27:375–91.
Bellary S. , Hassanein T. , Van Thiel D. H. Liver transplantation for Wilson's disease. J Hepatol, 1995. 23:373–81.
Belman A. L. , Lantos G. , Horoupian D. , et al. AIDS: calcification of the basal ganglia in infants and children. Neurology, 1986. 36:1192–9.
Bembi B. , Marchetti F. , Guerci V. , et al. Substrate reduction therapy in the infantile form of Tay-Sachs disease. Neurology, 2006. 66:278–80.
Benítez del Rosario M. A. , Montón F. , Salinas A. , et al. Charles Bonnet Syndrome and opioids. J Am Geriatr Soc, 2001. 49(2):235–6.
Bender H. U. , Almashanu S. , Steel G. , et al. Functional consequences of PRODH missense mutations. Am J Hum Genet, 2005. 76:409–20.
Benegal V. , Antony G. , Venkatasubramanian G. , Jayakumar P. N. Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence. Addict Biol, 2007. 12:122–32.
Benes F. , Vincent S. , Molloy R. Dopamine-immunoreactive axon varicosities form nonrandom contacts with GABA- immunoreactive neurons of rat medial prefrontal cortex. Synapse, 1993. 15:285–95.
Benes F. M. , Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology, 2001. 25(1):1–27.
Benes F. M. Altered glutamatergic and GABAergic mechanisms in the cingulated cortex of the schizophrenic brain. Arch Gen Psychiatry, 1995. 52:1015–18.
Benes F. Myelination of cortical hippocampal relays during late adolescence. Schizophr Bull, 1989. 15:589–93.
Benes F. Why does psychosis develop during adolescence and early adulthood? Curr Opin Psychiatry, 2003. 16:317–9.
Beniczky S. , Kéri S. , Vörös E. , et al. Complex hallucinations following occipital lobe damage. Eur J Neurol, 2002. 9:175–6.
Beninger R. J. , Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev, 1998. 22:335–45.
Benke T. , Karner E. , Seppi K. , et al. Subacute dementia and imaging correlates in a case of Fahr's disease. J Neurol Neurosurg Psychiatry, 2004. 75(8):1163–5.
Bennett J. , Dembure P. , Elsas L. Clinical and biochemical analysis of two families with type I and type II mannosidosis. Am J Med Genet, 1995. 55:21–6.
Bennett J. A. , Bullimore J. A. Use of ketamine hydrochloride anesthesia for radiotherapy young children. Br J Anaesth, 1973. 45(2):197–201.
Bennett M. R. Consciousness and hallucinations in schizophrenia: the role of synapse regression. Aust N Z J Psychiatry, 2008. 42:915–31.
Beraki S. , Aronsson F. , Karlsson H. , Ogren S. O. , Kristensson K. Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol Psychiatry, 2005. 10(3):299–308.
Beresford T. P. , Clapp L. Martin B. , et al. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol, 2005. 25(4):363–6.
Berg T. , Riise H. , Hensen G. , et al. Spectrum of mutations in alpha mannosidosis. Am J Hum Genet, 1999. 64:77–88.
Berger G. , Wood S. , Pantelis C. , et al. Implications of lipid biology for the pathogenesis of schizophrenia. Aust NZ J Psychiatry, 2002. 36:355–66.
Berger J. , Moser H. W. , Forss-Petter S. Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol, 2001. 14:305–12.
Berginer V. , Berginer J. , Korczyn A. , et al. Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study. Neurol Sci, 1994. 122:102–8.
Berginer V. , Foster N. , Sadowsky M. , et al. Psychiatric disorders in patients with cerebrotendinous xanthomatosus. Am J Psychiatry, 1988. 145:354–7.
Berginer V. , Salen G. , Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med, 1984. 311:1649–52.
Berginer V. M. , Foster N. L. , Sadowsky M. , et al. Psychiatric disorders in patients with cerebrotendinous xanthomatosis. Am J Psychiatry, 1988. 145:354–7.
Berkovic S. , Carpenter S. , Andermann F. , et al. Kuf's disease: a critical re-appraisal. Brain, 1988. 111:27–62.
Berrios G. E. Musical hallucinations. A historical and clinical study. Br J Psychiatry, 1990. 156:188–94.
Berrios G. E. Musical hallucinations. A historical and clinical study. Br J Psychiatry, 1990. 156:188–94.
Berrios G. Tactile hallucinations: conceptual and historical aspects. J Neurol Neurosurg Psychiatry, 1982. 45:285–93.
Berthier M. , Starkstein S. Acute atypical psychosis following a right hemisphere stroke. Acta Neurol Belg, 1987. 87:125–31.
Berthier M. , Starkstein S. Acute atypical psychosis following a right hemisphere stroke. Acta Neurol Belg, 1987. 87:125–31.
Besson J. A. A diagnostic pointer to adult metachromatic leucodystrophy. Br J Psychiatry, 1980. 137:186–7.
Betts T. A. (1981). Epilepsy and the mental hospital. In Epilepsy and Psychiatry. Reynolds E. H. and Trimble M. R. (Eds.). Edinburgh, Churchill: Livingstone, pp. 175–84.
Betts T. A. , Smith W. T. , Kelly R. E. Adult metachromatic leukodystrophy (sulphatide lipidosis) simulating acute schizophrenia: report of a case. Neurology, 1968. 18:1140–2.
Bexton W. H. , Heron W. , Scott T. H. Effects of decreased variation in the sensory environment. Can J Psychol, 1954. 8(2):70–6.
Bhatia M. , Jagawat T. , Choudhary S. Delusional parasitosis: a clinical profile. Int J Psychiatry Med, 2000. 30:83–91.
Bhidayasiri R. , Perlman S. L. , Pulst S.-M. , et al. Late-onset Friedreich Ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol, 2005. 62:1865–9.
Bhimani S. , Sarwar M. , Virapongse C. , et al. Computed tomography of cerebrovascular calcifications in postsurgical hypoparathyroidism. J Comput Assist Tomogr, 1985. 9(1):121–4.
Bialer P. A. Designer drugs in the general hospital. Psychiatr Clin North Am, 2002. 25(1):231–43.
Biancosino B. , Rocchi D. , Donà S. , et al. Efficacy of a short-term psychoeducational intervention for persistent non-organic insomnia in severely mentaly ill patients. Eur Psychiatr, 2006. 21:460–2.
Bilder R. M. , Volavka J. , Czobor P. , et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry, 2002. 52:701–7.
Binder R. Neurologically silent brain tumours in psychiatric hospital admissions: three cases and a review. J Clin Psychiatry, 1983. 44:94–7.
Bingham P. M. , Zimmerman R. A. , Donald-McGinn D. , et al. Enlarged Sylvian fissures in infants with interstitial deletion of chromosome 22q11. Am J Med Genet, 1997. 74:538–43.
Bird T. D. , Wijsman E. M. , Nochlin D. , et al. Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology, 1997. 48:949–54.
Birley J. L. T. DSM-III: from left to right or right to left? Br J Psychiatry, 1990. 157:116–8.
Bish J. P. , Ferrante S. M. , Donald-McGinn D. , et al. Maladaptive conflict monitoring as evidence for executive dysfunction in children with chromosome 22q11.2 deletion syndrome. Dev Sci, 2005. 8:36–43.
Black D. N. , Taber K. H. , Hurley R. A. Metachromatic leukodystrophy: a model for the study of psychosis. J Neuropsychiatr Clin Neurosci, 2003. 15:289–93.
Blackwood D. H. , Fordyce A. , Walker M. T. , et al. Schizophrenia and affective disorders – cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet, 2001. 69:428–33.
Bleuler E. (1911). Dementia praecox or the group of schizophrenias. Zinkin J. , translator. New York: International Universities Press.
Bleuler E. (1950). Dementia praecox or the group of schizophrenias [1911]. New York: International University Press.
Bleuler E. (1950). Dementia Praecox or the Group of Schizophrenias. 1911. New York: International Universities Press.
Bleuler M. Psychiatry of cerebral diseases. Br Med J, 1951. 24:1233–8.
Blom T. , Linder M. , Snow K. , et al. Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease. Hum Mol Genet, 2003. 12:257–72.
Bloom K. K. , Kraft W. A. Paranoia – an unusual presentation of hydrocephalus. Am J Phys Med Rehabil, 1998. 77(2):157–9.
Blouin J. L. , Dombroski B. A. , Nath S. K. , et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet, 1998. 20:70–3.
Bluhm R. L. , Miller J. , Lanius R. A. , et al. Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network. Schizophr Bull, 2007. 33:1004–12.
Blumer D. , Wakhlu S. , Davies K. , et al. Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications. Epilepsia, 1998. 39:478–86.
Bobes J. , Garc A-Portilla M. P. , Rejas J. , et al. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther, 2003. 29:125–47.
Bobes J. , Rejas J. , Garcia-Garcia M. , et al. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study. Schizophr Res, 2003. 62:77–88.
Boczkowski J. A. , Zeichner A. , DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychol, 1985. 53:666–71.
Bodani M. , Kopelman M. D. A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus. Lupus, 2003. 12:947–9.
Bodis-Wollner I. , Tagliati M. The visual system in Parkinson's disease. Adv Neurol, 1993. 60:390–4.
Boehme D. , Cottrell J. , Leonberg S. , et al. A dominant form of neuronal ceroid lipofuscinosis. Brain, 1971. 94:745–60.
Boer H. , Holland A. , Whittington J. , et al. Psychotic illness in people with Prader Willi Syndrome due to Chromosome 15 maternal uniparental disomy. Lancet, 12 2002. 359:135–6.
Bogelman G. , Hirschmann S. , Modai I. Olanzapine and Huntington's disease. J Clin Psychopharmacol, 2001. 21:245–6.
Bohnen N. , et al. Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol Psychiatry, 2003. 60:1745–8.
Boileau I. , Dagher A. , Leyton M. , et al. Modeling sensitisation to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry, 2006. 63(12):1386–95.
Boileau I. , Dagher A. , Leyton M. , et al. Modeling sensitisation to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry, 2006. 63(12):1386–95.
Boks M. P. , Liddle P. F. , Burgerhof J. G. , et al. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr Scand, 2004. 110:29–35.
Boks M. P. , Russo S. , Knegtering R. , Van Den Bosch R. J. The specificity of neurological signs in schizophrenia: a review. Schizophr Res, 2000. 43:109–16.
Boksman K. , Theberge J. , Williamson P. , et al. A 4.0-T fMRI study of brain connectivity during word fluency in first-episode schizophrenia. Schizophr Res, 2005. 75:247–63.
Boller F. , Boller M. , Denes G. , et al. Familial palilalia. Neurology, 1973. 23(10):1117–25.
Bolt J. M. W. Huntington's chorea in the West of Scotland. Br J Psychiatry, 1970. 116:259–70.
Bombin I. , Arango C. , Buchanan R. W. Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull, 2005. 31:962–77.
Bonelli R. M. , Wenning G. K. Pharmacological management of Huntington's disease: an evidence-based review. Curr Pharm Des, 2006. 12:2701–20.
Bonne O. , et al. Childhood imaginary companionship and mental health in adolescence. Child Psychiatry Hum Dev, 1999. 29:277–86.
Bonnet C. (1760). Essai Analytique sur les facultés de l'âme. Copenhagen: Philibert.
Bonnet C. (1769). Essai Analytique Sur les Facultés de L'âme. 2nd ed., Copenhague: Philbert.
Boos H. B. , et al. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry, 2007. 64(3):297–304.
Borison R. L. , Arvanitis L. A. , Miller B. G. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group. J Clin Psychopharmacol, 1996. 16:158–69.
Borit A. Communicating hydrocephalus causing aqueductal stenosis. Neuropaediatrie, 1976. 7(4):416–22.
Bosch E. P. , Hart M. N. Late adult-onset metachromatic leukodystrophy. Dementia and polyneuropathy in a 63-year-old man. Arch Neurol, 1978. 35:475–7.
Bostwick J. M. , Masterson B. J. Psychopharmacological treatment of delirium to restore mental capacity. Psychosomatics, 1998. 39:112–7.
Botstein D. , Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet, 2003. 33(Suppl):228–37.
Boue J. G. , Boue A. Effects of rubella virus infection on the division of human cells. Am J Dis Child, 1969. 118(1):45–8.
Bouras C. , Giannakopoulos P. , Good P. F. , et al. A laser microprobe mass analysis of trace elements in brain mineralizations and capillaries in Fahr's disease. Acta Neuropathol, 1996. 92(4):351–7.
Boutros N. N. , Bowers M. B. Jr. Chronic substance-induced psychotic disorders: state of the literature. J Neuropsychiatry Clin Neurosci, 1996. 8:262–9.
Boutros N. N. , Gelernter J. , Gooding C. D. , et al. Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary data. Biol Psychiatry, 2002. 51(8):683–6.
Boutros N. N. , Lisanby H. S. , Tokuno H. , et al. Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. Biol Psychiatry, 2001. 49(4):369–73.
Boutros N. N. , Lisanby S. H. , McClain-Furmanski D. , et al. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. J Psychiatr Res, 2005. 39(3):295–302.
Bowen J. D. , Larson E. B. Drug-induced cognitive impairment. Defining the problem and finding the solutions. Drugs Ageing, 1993. 3:349–57.
Bowers M. B. , Swigar M. E. Vulnerability to psychosis associated with hallucinogen use. Psychiatr Res, 1983. 9(2):91–7.
Braak H. , Braak E. Pathoarchitectonic pattern of iso- and allocortical lesions in juvenile and adult neuronal ceroid lipofuscinoses. J Inherit Metabol Dis, 1993. 16:259–62.
Bracha H. , et al. High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry, 1989. 146:526–8.
Bradbury T. N. , Miller G. A. Season of birth in schizophrenia: a review of evidence, methodology, and etiology. Psychol Bull, 1985. 98(3):569–94.
Brady K. T. , Lydiard R. B. , Malcolm R. , Ballenger J. C. Cocaine-induced psychosis. J Clin Psychiatry, 1991. 52:509–12.
Brady K. T. , Lydiard R. B. , Malcolm R. , Cocaine-induced psychosis. J Clin Psychiatry, 1991. 52(12):509–12.
Brady K. T. , Sonne S. , Randall C. L. , Adinoff B. , Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend, 1995. 39(1):69–71.
Brady R. O. , Filling-Katz M. R. , Barton N. W. , et al. Niemann-Pick disease types C and D . Neurol Clin, 1989. 7:75–88.
Braff D. L. , Freedman R. , Schork N. J. , et al. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull, 2007. 33:21–32.
Braff D. L. , Geyer M. A. , Swerdlow N. R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl), 2001. 156:234–58.
Braff D. L. , Geyer M. A. , Swerdlow N. R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology, 2001. 156(2–3):234–58.
Brain W. (1985). Intracranial tumour. In Brain's Clinical Neurology, Bannister R. (Ed.). London: Oxford University Press. pp. 223–55.
Bramon E. , Rabe-Hesketh S. , Sham P. , Murray R. M. , Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res, 2004. 70(2–3):315–29.
Brandon N. J. , Handford E. J. , Schurov I. , et al. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci, 2004. 25:42–55.
Brandt J. , Folstein S. E. , Folstein M. F. Differential cognitive impairment in Alzheimer's disease and Huntington's disease. Ann Neurol, 1988. 23:555–61.
Brasic J. Hallucinations. Percept Mot Skills, 1998. 86:851–77.
Brauer C. , Morrison R. S. , Silberzweig S. B. , et al. The cause of delirium in patients with hip fracture. Arch Intern Med, 2000. 160:1856–60.
Braun C. , et al. Brain modules of hallucination: an analysis of multiple patients with brain lesions. J Psych Neurosci, 2003. 28:432–9.
Braun C. M. , Lapierre D. , Hodgins S. , et al. Neurological soft signs in schizophrenia: are they related to negative or positive symptoms, neuropsychological performance, and violence? Arch Clin Neuropsychol, 1995. 10:489–509.
Braver T. S. , Barch D. M. , Cohen J. D. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry, 1999. 46:312–28.
Bray G. A. , Dahms W. T. , Swerdloff R. S. , et al. The Prader-Willi syndrome: a study of 40 patients and a review of the literature. Medicine, 1982. 62:59–80.
Breakspear M. , Terry J. R. , Friston K. J. , et al. A disturbance of nonlinear interdependence in scalp EEG of subjects with first episode schizophrenia. Neuroimage, 2003. 20:466–78.
Breen L. , Morris H. , Alperin J. , et al. Juvenile Niemann-Pick disease with vertical supranuclear opthalmoplegia. Arch Neurol, 1981. 38:388–90.
Breese G. R. , Knapp D. J. , Moy S. S. Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neurosci Biobehav Rev, 2002. 26(4):441–55.
Breier A. , Malhotra A. K. , Pinals D. A. , et al. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry, 1997; 154(6):805–11.
Breier A. , Malhotra A. K. , Pinals D. A. , Weisenfeld N. I. , Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry, 1997. 154:805–11.
Breier A. , Su T. P. , Saunders R. , et al. Schizophrenia is associated with elevated amphetamineinduced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA, 1997. 94:2569–74.
Breier A. , Sutton V. K. , Feldman P. D. , et al. Olanzapine in the treatment of dopamimeticinduced psychosis in patients with Parkinson's disease. Biol Psychiatry. 2002. 52:438–45.
Breier A. Serotonin, schizophrenia and antipsychotic drug-action. Schizophr Res, 1995. 14(3):187–202.
Breitbart W. , Gibson C. , Tremblay A. The delirium experience: delirium recall and deliriumrelated distress in hospitalised patients with cancer, their spouse/care givers, and their nurses. Psychosomatics, 2002. 43:183–94.
Breitbart W. , Tremblay A. , Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics, 2002. 43:175–82.
Breitner J. C. , Husain M. M. , Figiel G. S. , et al. Cerebral white matter disease in late-onset paranoid psychosis. Biol Psychiatry, 1990. 28:266–74.
Brenner M. , Johnson A. B. , Boespflug-Tanguy O. , et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet, 2001. 27:117–20.
Bret P. , Chazal J. Chronic (“normal pressure”) hydrocephalus in childhood and adolescence. A review of 16 cases and reappraisal of the syndrome. Childs Nerv Syst, 1995. 11(12):687–91.
Breuning M. H. Phenotypic variability: genetics and chance–deletion 22q11 and schizophrenia. Ned Tijdschr Geneeskd, 2002. 146:2016–19.
Brewer G. J. , Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore), 1992. 71:139–64.
Brewer G. J. Interactions of zinc and molybdenum with copper in therapy of Wilson's disease. Nutrition, 1995. 11(1 Suppl):114–16.
Brewer G. J. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs, 2005. 19:185–92.
Brewer W. J. , et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry, 2001. 158(1):107–15.
Brewerton T. D. The phenomenology of psychosis associated with complex partial seizure disorder. Ann Clin Psychiatry, 1997. 9:31–51.
Brill H. , Nahas G. (1984). Cannabis intoxication and mental illness. In Marijuana in Science and Medicine, Nahas G. (Ed.). New York: Raven Press.
Brockmann K. , Dechent P. , Wilken B. , et al. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology, 2003. 60:819–25.
Brodaty H. , Mitchell P. , Luscombe G. , et al. Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q. Hum Genet, 2002. 110:8–14.
Brodaty H. M. P. , Luscombe G. , Kwok J. B. , et al. Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the BGC1 locus on chromosome 14q. Hum Genet, 2002. 110:8–14.
Broderick P.A. , Rahni D. N. , Zhou Y. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior. Prog Neuropsychopharmacol Biol Psychiatry, 2003. 27(6):1037–54.
Brody S. A. , Geyer M. A. , Large C. H. Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice. Psychopharmacology (Berl), 2003. 169(3–4):240–6.
Brouwers P. , Cox C. , Martin A. , et al. Differential perceptualspatial impairment in Huntington's and Alzheimer's dementias. Arch Neurol, 1984. 41:1073–6.
Brown A. S. , Begg M. D. , Gravenstein S. , et al. Serologic evidence for prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry, 2004. 61:774–80.
Brown A. S. , Cohen P. , Greenwald S. , Susser E. Nonaffective psychosis after prenatal exposure to rubella. Am J Psychiatry, 2000. 157(3):438–43.
Brown A. S. , Cohen P. , Harkavy-Friedman J. , et al. A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry, 2001. 49(6):473–86.
Brown A. S. , Hooton J. , Schaefer C. A. , et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry, 2004. 161(5):889–95.
Brown A. S. , Schaefer C. A. , Quesenberry C. P. Jr., et al. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry, 2005. 162(4):767–73.
Brown A. S. , Schaefer C. A. , Quesenberry C. P. Jr., Shen L. , Susser E. S. No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia. Am J Psychiatry, 2006. 163(12):2178–80.
Brown A. S. , Schaefer C. A. , Wyatt R. J. , et al. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull, 2000. 26(2):287–95.
Brown A. S. , Susser E. (1999). Plausibility of prenatal rubella, influenza, and other viral infections as risk factors for schizophrenia. In Prenatal Exposures in Schizophrenia, Susser E. , Brown A. S. , and Gorman J. M. (Eds.). Washington, DC: American Psychiatric Press, Inc., pp. 113–31.
Brown A. S. , Susser E. S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev, 2002. 8(1):51–7.
Brown E. S. , Nejtek V. A. , Perantie D.C. , Rajan Thomas N. , Rush A. J. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation. J Clin Psychopharmacol, 2003. 23(4):384–8.
Brown G. C. , Murphy R. P. Visual synptoms associated with choroidal neovascularization. Photopsias and the Charles Bonnet syndrome. Arch Ophthalmol, 1992. 110:1251–6.
Brown G. G. , Eyler L. T. Methodological and conceptual issues in functional magnetic resonance imaging: applications to schizophrenia research. Annu Rev Clin Psychol, 2006. 2:51–81.
Brown T. (2000). Basic mechanisms in the pathogenesis of delirium. In Psychiatric care of the medical patient, Stoudemire A. , Fogel B. , Greenberg D. (Eds.). New York: Oxford University Press, pp. 571–80.
Brown T. M. , Boyle M. F. Delirium. Br Med J, 2002. 325:644–7.
Brownlie B. E. , Rae A. M. , Walshe J. W. , et al. Psychoses associated with thyrotoxicosis – ‘thyrotoxic psychosis.’ A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol, 2000. 142:438–44.
Bruens J. H. Psychoses in epilepsy. Psychiatr Neurol Neurochir, 1971. 74:174–92.
Bruton C. J. , Stevens J. R. , Frith C. D. Epilepsy, psychosis, and schizophrenia: clinical and neuropathologic correlations. Neurology, 1994. 44:34–42.
Brzustowicz L. M. , Hodgkinson K. A. , Chow E. W. , et al. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science, 2000. 288:678–82.
Brzustowicz L. M. , Honer W. G. , Chow E. W. , et al. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet, 1999. 65:1096–103.
Buchanan D. , Abram H. Psychotic behaviour resulting from a lateral ventricle meningioma: a case report. Disease Nerv Syst, 1975. 36(7):400–1.
Buchanan R. W. , Francis A. , Arango C. , et al. Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry, 2004. 161:322–31.
Buchanan R. W. , Heinrichs D. W. The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res, 1989. 27:335–50.
Buchsbaum M. S. , Buchsbaum B. R. , Hazlett E. A. , et al. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry, 2007b. 164:1072–81.
Buchsbaum M. S. , Christian B. T. , Lehrer D. S. , et al. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophr Res, 2006. 85:232–44.
Buchsbaum M. S. , Hazlett E. A. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull, 1998. 24:343–64.
Buchsbaum M. S. , Haznedar M. M. , Aronowitz J. , et al. FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol. Schizophr Res, 2007. 94:293–305.
Buchsbaum M. S. , Ingvar D. H. , Kessler R. , et al. Cerebral glucography with positron emission tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry, 1982. 39:251–59.
Buchsbaum M. S. , Nenadic I. , Hazlett E. A. , et al. Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res, 2002. 54:141–50.
Buchsbaum M. S. , Nuechterlein K. H. , Haier R. J. , et al. Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography. Br J Psychiatry, 1990. 156:216–27.
Buchsbaum M. S. , Someya T. , Teng C. Y. , et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry, 1996. 153:191–9.
Buchsbaum M. S. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness. Clin Neurosci, 1995. 3:122–30.
Buckley P. , Stack J. P. , Madigan C. , et al. Magnetic resonance imaging of schizophrenia-like psychosis associated with cerebral trauma: clinicopathological correlates. Am J Psychiatry, 1993. 150:146–8.
Budka H. , Sluga E. , Heiss W. D. Spastic paraplegia associated with Addison's disease: adult variant of adreno-leukodystrophy. J Neurol, 1976. 213:237–50.
Buka S. L. , Tsuang M. T. , Torrey E. F. , et al. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry, 2001. 58(11):1032–7.
Bulayeva K. B. , Glatt S. J. , Bulayev O. A. , et al. Genome-wide linkage scan of schizophrenia: a cross-isolate study. Genomics, 2007. 89:167–77.
Bullmore E. T. , Frangou S. , Murray R. M. The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophr Res, 1997. 28:143–56.
Bullmore E. T. , Woodruff P. W. , Wright I. C. , et al. Does dysplasia cause anatomical dysconnectivity in schizophrenia? Schizophr Res, 1998. 30:127–35.
Burdick K. E. , Hodgkinson C. A. , Szeszko P. R. , et al. DISC1 and neurocognitive function in schizophrenia. Neuroreport, 2005. 16:1399–402.
Burgovne K. , Swartz R. , Ananth J. Porphyria: Reexamination of psychiatric implications. Psychother Psychosom, 1995. 64:121–30.
Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry, 2002. 73:535–41.
Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry, 2002. 73:535–41.
Burkhardt C. , Kelly J. P. , Lim Y. , et al. Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol, 1993. 33:512–17.
Burnam M. A. , Morton S. C. , McGlynn E. A. , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. J Addict Dis, 1995. 14:111–34.
Burns A. , Gallagley A. , Byrne J. Delirium. J Neurol Neurosurg Psychiatry, 2004. 75:362–7.
Burns A. , Jacoby R. , Levy R. Psychiatric phenomena in Alzheimer's disease, II: disorders of perception. Br J Psychiatry, 1990. 157:78–81, 92–4.
Burns R. S. , Lerner S. E. , Corrado R. , et al. Phencyclidine – states of acute intoxication and fatalities. West J Med, 1975. 123(5):345–9.
Burns R. S. , Lerner S. E. Perspectives – acute phencyclidine intoxication. Clin Toxicol, 1976. 9(4):477–501.
Butters N. , Wolfe J. , Granholm E. , et al. An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease. Cortex, 1986. 22:11–32.
Buyse G. , Mertens L. , Di Salvo G. , et al. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology, 2003. 60:1679–81.
Cadet J. L. , Rickler K. C. , Weinberger D. L. (1986). The clinical neurologic examination in schizophrenia. In The Neurology of Schizophrenia, Nasrallah H. A. and Weinberger D. L. (Eds.). New York: Elsevier.
Caine S. B. , Koob G. F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther, 1994. 270:209–18.
Calabrese J. R. , Keck P. E. Jr. , Macfadden W. , et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry, 2005. 162:1351–60.
Caligiuri M. P. , Lohr J. B. , Jeste D. V. Parkinsonism in neurolepticnaive schizophrenic patients. Am J Psychiatry, 1993. 150:1343–8.
Calkins M. E. , Dobie D. J. , Cadenhead K. S. , et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull, 2007. 33:33–48.
Callagy C. , O'Neill G. , Murphy S. , et al. Adult neuronal ceroid lipofuscinosis (Kufs' disease) in two siblings of an Irish family. Clin Neuropathol, 2000. 19:109–18.
Callender J. S. Non-progressive familial idiopathic intracranial calcification: a family report. J Neurol Neurosurg Psychiatry, 1995. 59(4):432–4.
Callicott J. H. , Bretolino A. , Mattay V. S. , et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex, 2000. 10;1078–92.
Callicott J. H. , Straub R. E. , Pezawas L. , et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA, 2005. 102:8627–32.
Callicott, J. H. , et al. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry, 2003. 160(12):2209–15.
Callinan P. A. , Feinberg A. P. The emerging science of epigenomics. Hum Mol Genet, 2006. 15 Spec No 1:R95–101.
Calsin R. J. , Yonker R. D. , Lemming M. R. , et al. Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Crim Behav Ment Health, 2005. 15:236–48.
Camargo L. M. , Collura V. , Rain J. C. , et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry, 2007. 12:74–86.
Cami J. , Farre M. , Mas M. , et al. Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): psychomotor performance and subjective effects. J Clin Psychopharmacol, 2000. 20:455–66.
Camp N. J. , Neuhausen S. L. , Tiobech J. , et al. Genomewide multipoint linkage analysis of seven extended ocaliz pedigrees with schizophrenia, by a Markov-chain Monte Carlo method. Am J Hum Genet, 2001. 69:1278–89.
Campbell L. E. , Daly E. , Toal F. , et al. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain, 2006. 129:1218–28.
Campo J. , Stowe R. , Slomka G. , et al. Psychosis as a presentation of physical disease in adolescence: a case of Niemann-Pick disease type C. Dev Med Child Neurol, 1998. 40:126–9.
Campos Y. , Garcia A. , Eiris J. , et al. Mitochondrial myopathy, cardiomyopathy and psychiatric illness in a Spanish family harbouring the mtDNA 3303C > T mutation. J Inherit Metab Dis, 2001. 24(6):685–7.
Campos Y. , Garcia A. , Eiris J. , et al. Mitochondrial myopathy, cardiomyopathy and psychiatric illness in a Spanish family harbouring the mtDNA 3303C>T mutation. J Inherit Metab Dis, 2001. 24:685–7.
Campuzano V. , Montermini L. , Molto M. D. , et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science, 1996. 271:1423–7.
Cancelli I. , Marcon G. , Balestrieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol, 2004. 19:577–84.
Candela S. , Manschreck T. Neurological soft signs in schizophrenia. Research findings and clinical relevance. Psychiatr Ann, 2003. 33:157–66.
Cannon M. , Caspi A. , Moffitt T. E. , et al. Evidence for early- childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry, 2002. 59:449–56.
Cannon M. , Caspi A. , Moffitt T. E. , et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry, 2002. 59:449–56.
Cannon T. D. , Hennah W. , van Erp T. G. , et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry, 2005. 62:1205–13.
Cantor S. , Pearce J. , Pezzot-Pearce T. , et al. The group of hypotonic schizophrenics. Schiz Bull, 1981. 7:1–11.
Cantu T. G. , Korek J. S. Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med, 1991. 114:1027–34.
Cao Q. , Martinez M. , Zhang J. , et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics, 1997. 43:1–8.
Cardno A. G. , Gottesman I. I. Twin studies of schizophrenia: from bow-and-arrow concordances to Star Wars Mx and functional genomics. Am J Med Genet, 2000. 97:12–17.
Cardon L. R. , Abecasis G. R. Using haplotype blocks to map human complex trait loci. Trends Genet, 2003. 19:135–40.
Cardon L. R. , Bell J. I. Association study designs for complex diseases. Nat Rev Genet, 2001. 2:91–9.
Carey J. C. , Viskochil D. H. Neurofibromatosis type 1: a model condition for the study of the molecular basis of variable expressivity in human disorders. Am J Med Genet, 1999. 89:7–13.
Carey K. B. Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach. Community Ment Health J, 1996. 32:291–306.
Carls K. A. , Ruehter V. L. An evaluation of phencyclidine (PCP) psychosis: a retrospective analysis at a state facility. Am J Drug Alcohol Abuse, 2006. 32(4):673–8.
Carlson R. Frontal lobe lesions masquerading as psychiatric disturbances. Can Psychiatr Assoc, 1977. 22:315–8.
Carlsson A. , Waters N. , Holm-Waters S. , et al. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Ann Rev Pharmacol Toxicol, 2001. 41:237–60.
Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 1988. 1(3):179–86.
Carlsson M. , Carlsson A. Schizophrenia – a subcortical neurotransmitter imbalance syndrome. Schizophr Bull, 1990. 16(3):425–32.
Carota A. , Staub F. , Bogousslavsky J. Emotions, behaviours and mood changes in stroke. Curr Opin Neurol, 2002. 15:57–69.
Carpenter W. T. , Koenig J. I. The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology, 2008. 33:2061–79. [Epub Nov 28, 2007.]
Carpenter W. T. The schizophrenia ketamine challenge study debate. Biol Psychiatry, 1999. 46(8):1081–91.
Carson B. , et al. Third ventricular choroid plexus papilloma with psychosis: case report. J Neurosurg, 1997. 87(1):103–5.
Carstea E. , Morris J. , Coleman K. , et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science, 1997. 277:228–31.
Carter C. S. , et al. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry, 2001. 158(9):1423–8.
Carter M. , Mackinnon A. , Copolov D. Patients' strategies for coping with auditory hallucinations. J Nerv Ment Dis, 1996. 184:159–64.
Casanova M. F. , Araque J. M. Mineralization of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Res, 2003. 121(1):59–87.
Casanova M. F. Wernicke's disease and schizophrenia: a case report and review of the literature. Int J Psychiatry Med, 1996. 26:319–28.
Cascino G. D. , Adams R. D. Brainstem auditory hallucinosis. Neurology, 1986. 36(8):1042–7.
Caspi A. , et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry, 2005. 57(10):1117–27.
Caspi A. , Moffitt T. E. , Cannon M. , et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry, 2005. 57:1117–27.
Cassem E. H. , Lake C. R. , Boyer W. F. (1994). Psychopharmacology in the ICU. In The Pharmacologic Approach to the Critically Ill Patient, Chernow B. (Ed.). 3rd ed. Baltimore, Maryland: Williams and Wilkins, pp. 651–65.
Castagnini A. , Bertelsen A. , Munk-Jorgensen P. , et al. The relationship of reactive psychosis and ICD-10 acute and transient psychotic disorders: evidence from a case register-based comparison. Psychopathology, 2007. 40:47–53.
Castellote A. , Vera J. , Vasquez E. , et al. MR in adrenoleukodystrophy: atypical presentation as bilateral frontal demyelination. AJNR Am J Neuroradiol, 1995. 16(Suppl 4):814–15.
Cataldo A. , Peterhoff C. , Troncoo J. , et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenelin mutations. Am J Pathol, 2000. 157:277–86.
Catani M. , Ffytche D. H. The rises and falls of disconnection syndromes. Brain, 2005. 128:2224–39.
Caton C. L. , Drake R. E. , Hasin D. S. , et al. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry, 2005. 62:137–45.
Caton C. L. , Hasin D. S. , Shrout P. E. , et al. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br J Psychiatry, 2007. 190:105–11.
Caton C. L. M. , Samet S. , Hasin D. S. When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders. J Psychiatr Pract, 2000. 6:256–66.
Catts S. V. , Ward P. B. , Lloyd A. , et al. Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia. Aust NZ J Psychiatry, 1997. 31(1):17–26.
Catts V. S. , Catts S. V. , McGrath J. J. , et al. Apoptosis and schizophrenia: a pilot study based on dermal fibroblast cell lines. Schizophr Res, 2006. 84(1):20–8.
Cavelier L. , Jazin E. E. , Eriksson I. , et al. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics, 1995. 29(1):217–24.
Cengiz N. , Osbenli T. , Onar M. , et al. Adult metachromatic leukodystrophy: three cases with normal nerve conduction velocities in a family. Acta Neurol Scand, 2002. 105:454–7.
Censits D. M. , et al. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res, 1997. 24(3):289–98.
Centers for Disease Control and Prevention . CDC recommendations regarding selected conditions affecting women's health. MMWR Morb Mortal Wkly Rep, 49(RR-2):57–75. 2000.
Cerizza M. , Nemni R. , Tamma F. Adult metachromatic leucodystrophy: an underdiagnosed disease? (letter). J Neurol Neurosurg Psychiatry, 1987. 50:1710–12.
Cerrato P. , et al. Complex musical hallucinosis in a professional musician with a left subcortical haemorrhage. J Neurol Neurosurg Psychiatry, 2001. 71(2):280–1.
Cerrato P. , Imperiale D. , Giraudo M. , et al. Complex musical hallucinosis in a professional musician with a left subcortical haemorrhage. J Neurol Neurosurg Psychiatry, 2001. 71:280–1.
Cerrato P. , Imperiale D. , Giraudo M. , et al. Complex musical hallucinosis in a professional musician with left subcortical haemorrhage. J Neurol Neurosurg Psychiatry, 2001. 71:280–1.
Chabot B. , Roulland C. , Dollfus S. Schizophrenia and familial idiopathic basal ganglia calcification: a case report. Psychol Med, 2001. 31(4):741–7.
Chakravarti A. Population genetics – making sense out of sequence. Nat Genet, 1999. 21:56–60.
Chambers R. A. , Krystal J. H. , Self D. W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry, 2001. 50:71–83.
Chan R. C. , Chen E. Y. Blink rate does matter: a study of blink rate, sustained attention, and neurological signs in schizophrenia. J Nerv Ment Dis, 2004. 192:781–3.
Chan S. W. , Reade P. C. Tinnitus and temporomandibular pain-dysfunction disorder. Clin Otolaryngol Allied Sci, 1994. 19(5):370–80.
Chan Y.-C. Aripiprazole treatment for psychosis associated with Freidreich's ataxia. Gen Hosp Psychiatry, 2005. 27:372–8.
Chandler D. W. , Spicer G. Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders. Community Ment Health J, 2006. 42:405–25.
Chang P. , Steinberg M. Alcohol withdrawal. Med Clin North Am, 2001. 85:1191–212.
Chanock S. J. , Manolio T. , Boehnke M. , et al. Replicating genotype–phenotype associations. Nature, 2007. 447:655–60.
Chapman A. G. , Meldrum B. S. Excitatory amino acid antagonists and epilepsy. Biochem Soc Trans, 1993. 21:106–10.
Chapman F. , et al. Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. Am J Psychiatry, 1999. 156:1983–5.
Charles N. , Vighetto A. , Pialat J. , et al. Dementia and psychiatric disorders in Kufs disease. Rev Neurol (Paris), 1990. 146:752–6.
Charles-Nicolas A. J. [Does chronic psychosis due to amphetamines abuse exist? Study of 25 drug addicts.] Nouv Presse Med, 1976. 5(37):2447–50. French.
Chatterjee A. , Chakos M. , Koreen A. , et al. Prevalence and clinical correlates extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry, 1995. 152:1724–9.
Cheer J. F. , Wassum K. M. , Heien M. L. A. V. , et al. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci, 2004. 24(18):4393–400.
Chemerinski E. , Ho B. C. , Flaum M. , et al. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Compr Psychiatry, 2002. 43:393–6.
Chen C. , et al. Olfactory auras in patients with temporal lobe epilepsy. Epilepsia, 2003. 44(2):257–60.
Chen C. K. , Lin S. K. , Sham P. C. , et al. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet, 2005. 136(1):87–91.
Chen C. K. , Lin S. K. , Sham P. C. , et al. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet, 2005. 136:87–91.
Chen C. K. , Lin S. K. , Sham P. C. , et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med, 2003. 33:1407–14.
Chen C. S. , Lin S. F. Charles Bonnet syndrome and multiple sclerosis. Am J Psychiatry, 2001. 158:1158–9.
Chen E. Y. , Hut C. L. , Chan R. C. , et al. A 3-year prospective study of neurological soft signs in firstepisode schizophrenia. Schizophr Res, 2005. 75:45–54.
Chen E. Y. , Shapleske J. , Luque R. , et al. The Cambridge neurological inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res, 1995. 56:183–204.
Chen G. D. , Jastreboff P. J. Salicylate-induced abnormal activity in the inferior colliculus of rats. Hear Res, 1995. 82(2):158–78.
Chen W. J. , Chang C. H. , Liu S. K. , et al. Sustained attention deficits in nonpsychotic relatives of schizophrenic patients: a recurrence risk ratio analysis. Biol Psychiatry, 2004. 55:995–1000.
Chen W. Y. , Shi Y. Y. , Zheng Y. L. , et al. Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet, 2004a. 13:2991–5.
Chen X. , Wang X. , O'Neill A. F. , et al. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry, 2004b. 9:962–7.
Chen Y. , et al. Motion perception in schizophrenia. Arch Gen Psychiatry, 1999. 56:149–54.
Chengappa K. N. , Goldstein J. M. , Greenwood M. , et al. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clin Ther, 2003. 25:530–41.
Cherland E. , Fitzpatrick R. Psychotic side effects of psychostimulants: a 5-year review. Can J Psychiatry, 1999. 44(8):811–3.
Cherlow D. G. , Dymond A. M. , Crandall P. H. , et al. Evoked response and after-discharge thresholds to electrical stimulation in temporal lobe epileptics. Arch Neurol, 1977. 34:527–31.
Chern C. , Buetler E. , Kuhl W. , et al. Characterization of heteropolymeric hexosaminidase A in human x mouse hybrid cells. Proc Natl Acad Sci USA, 1976. 73:3637–40.
Chess S. , Korn S. , Fernandez P. (1971). Psychiatric Disorders of Children with Congenital Rubella. New York: Brunner/Mazel.
Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr, 1977. 7(1):69–81.
Cheyne J. A. , Rueffer S. D. , Newby-Clark I. R. Hypnagogic and hypnopompic hallucinations during sleep paralysis: neurological and cultural construction of the nightmare. Conscious Cogn, 1999. 8(3):319–37.
Chien Y. , Lee N. , Tsai L. , et al. Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year. J Inherit Metabol Dis, 2007. 30: 826.
Chinnery P. , Majamaa K. , Turnbull D. , et al. Treatment for mitochondrial disorders. Cochrane Database Syst Rev, 2006. 1:CD004426.
Chinnery P. E. , Howell N. , Lightowlers R. N. , et al. MELAS and MERRF – The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain, 1998. 121:1889–94.
Chinnery P. F. , Schon E. A. Mitochondria . J Neurol Neurosurg Psychiatry, 2003. 74:1188–99.
Chisholm S. E. , Deniston O. L. , Igrisan R. M. , et al. Prevalence of confusion in elderly hospital patients. J Gerontol Nurs, 1982. 8:87–96.
Chiu H. F. , Lam L. C. , Shum P. P. , et al. Idiopathic calcification of the basal ganglia. Postgrad Med J, 1993. 69(807):68–70.
Choi J. S. , Kang D. H. , Kim J. J. , et al. Decreased caudal anterior cingulate gyrus volume and positive symptoms in schizophrenia. Psychiatry Res, 2005. 139:239–47.
Cholden L. S. , Kurland A. , Savage C. Clinical reactions and tolerance to LSD in chronic schizophrenia. J Nerv Ment Dis, 1955. 122(3):211–21.
Chow E. W. , Mikulis D. J. , Zipursky R. B. , et al. Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry, 1999. 46:1436–42.
Chow E. W. , Watson M. , Young D. A. , et al. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res, 2006. 87:270–78.
Chow E. W. , Zipursky R. B. , Mikulis D. J. , et al. Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry, 2002. 51:208–15.
Chowdari K. V. , Mirnics K. , Semwal P. , et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet, 2002. 11:1373–80.
Chowrimootoo G. F. , Andoh J. , Seymour C. A. Western blot analysis in patients with hypocaeruloplasminaemia. QJM, 1997. 90:197–202.
Chroni E. , Lekka N. P. , Tsibri E. , et al. Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson's disease. J Neuropsy-chiatry Clin Neurosci, 2001. 13:531–2.
Chua S. E. , McKenna P. J. Schizophrenia – a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry, 1996. 166:563–82.
Chui H. C. , Lyness S. A. , Sobel E. , et al. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol, 1994. 51:676–81.
Chumakov I. , Blumenfeld M. , Guerassimenko O. , et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA, 2002. 99:13675–80.
Chung Y. S. , Ravi S. D. , Borge G. F. Psychosis in Wilson's disease. Psychosomatics, 1986. 27:65–6.
Claridge G. Single indicator of risk for schizophrenia: probable fact or likely myth? Schizophr Bull, 1994. 20:151–68.
Clark A. G. The role of haplotypes in candidate gene studies. Genet Epidemiol, 2004. 27:321–33.
Clark C. M. , Kessler R. , Buchsbaum M. S. , et al. Correlational methods for determining regional coupling of cerebral glucose metabolism: a pilot study. Biol Psychiatry, 1984. 19:663–78.
Clark J. M. , Marks M. P. , Adalsteinsson E. , et al. MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology, 1996. 46:223–7.
Clarke D. J. , Boer H. , Webb T. , et al. Prader-Willi syndrome and psychotic symptoms: 1. Case descriptions and genetic studies. J Intellect Disabili Res, 1998. 42:159–65.
Clarke D. Prader-Willi syndrome and psychotic symptoms: 2. A preliminary study of prevalence using the Psychopathology Assessment Schedule for Adults with Developmental Disability checklist. J Intellect Disabil Res, 1998. 42:451–4.
Claude H. , Ey H. Troubles psychosensoriels et etats oniriques dans l'encephalite epidemique chronique. Presse Med (Paris), 1933. 104:1281–5.
Cleghorn J. M. , et al. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J Clin Psychiatr, 1991. 52:26–30.
Close P. J. , Sinnott S. J. , Nolan K. T. Adrenoleukodystrophy: a case report demonstrating unilateral abnormalities. Pediatr Radiol, 1993. 23:400–1.
Cloud B. , Carew T. G. , Rothenberg H. , et al. A case of paraphrenia: integrating neuropsychological and SPECT data. J Geriatr Psychiatry Neurol, 1996. 9:146–53.
Cochran S. M. , Fujimura M. , Morris B. J. , et al. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse, 2002. 46(3):206–14.
Cochran S. M. , Kennedy M. , McKerchar C. E. , et al. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology, 2003. 28(2):265–75.
Cockerell O. C. , Moriarty J. , Trimble M. , et al. Acute psychological disorders in patients with epilepsy: a nation-wide study. Epilepsy Res, 1996. 25:119–31.
Cogan D. G. Visual hallucinations as release phenomena. Albrecht v Graefes Arch klin exp Ophthal. 1973. 188:139–50.
Cogan D. Visual hallucinations as release phenomena. Graefes Arch Clin Exp Opthal, 1973. 188:139–50.
Cohen B. D. , Rosenbaum G. , Gottlieb J. S. , et al. Comparison of phencyclidine hydrochloride (sernyl) with other drugs – simulation of schizophrenic performance with phencyclidine hydrochloride (sernyl), lysergic-acid diethylamide (Lsd-25), and amobarbital (amytal) sodium. 2. Symbolic and sequential thinking. Arch of Gen Psychiatry, 1962. 6(5):395–401.
Cohen C. R. , Duchesneau P. M. , Weinstein M. A. Calcification of the basal ganglia as visualized by computed tomography. Radiology, 1980. 134(1):97–9.
Cohen L. , Dehaene S. Specialization within the ventral stream: the case for the visual word form area. Neuroimage, 2004. 22:466–76.
Cohen S. Lysergic-acid diethylamide – side-effects and complications. J Nerv Ment Dis, 1960. 130(1):30–40.
Cohen S. Y. , Safran A. B. , Tadayoni T. , et al. Visual hallucinations immediately after macular photocoagulation. Am J Ophthalmol, 2000. 129:815–6.
Cohen-Mansfield J. Nonpharacologic interventions for inappropriate behaviours in dementia: a review, summary, and critique. Am J Geriatr Psychiatry, 2001. 9:361–81.
Cole J. C. , Sumnall H. R. Altered states: the clinical effects of ecstasy. Pharmacol Therapeutics, 2003. 98(1):35–58.
Coleman M. J. , Levy D. L. , Lenzenweger M. F. , Holzman P. S. Thought disorder, perceptual aberrations, and schizotypy. J Abnorm Psychol, 1996. 105:469–73.
Collerton D. , et al. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual–perceptual and attentional–executive dementia. Dement Geriatr Cogn Disord, 2003. 16:229–37.
Collerton D. , Perry E. , McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci., 2005. 28:737–94.
Collerton D. , Perry E. , McKeith L. Why people see things that are not there: a novel Perception and Attention Deficit model for recurrent complex visual hallucinations. Behav Brain Sci, 2005. 28:737–57.
Collier B. B. Ketamine and conscious mind. Anaesthesia, 1972. 27(2):120–34
Collins L. , Stone L. Pain sensitivity, age and activity level in chronic schizophrenics and normals. Br J Psychiatry, 1966. 112:33–5.
Collins P. Y. , Varma V. K. , Wig N. N. , et al. Fever and acute brief psychosis in urban and rural settings in North India. Br J Psychiatry, 1999. 174:520–4.
Collins V. J. , Gorospe C. A. , Rovenstine E. A. Intravenous nonbarbiturate, nonnarcotic analgesics: preliminary studies. Cyclohexylamines. Anesth Analg, 1960. 39:302–6.
Commission on Clasification and Terminology of the Intemational League Against Epilepsy . Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia, 1981(4). 22:489–501.
Conlon P. , Trimble M. R. , Rogers D. A study of epileptic psychosis using magnetic resonance imaging. Br J Psychiatry, 1990. 156:231–5.
Connell P. H. (1958). Amphetamine Psychosis. Maudsley Monograph Number 5. London: Chapman & Hall, Ltd.
Connell P. H. (1958). Amphetamine Psychosis. Maudsley Monographs No. 5. New York: Oxford University Press, pp. 15–36.
Constantinidis J. , Wisniewski K. , Wisniewski T. The adult and a new late adult forms of neuronal ceroid lipofuscinosis. Acta Neuropathol, 1992. 83:461–8.
Conzelmann E. , Sandhoff K. Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci, 1983. 6:58–71.
Cook C. E. , Brine D. R. , Jeffcoat A. R. , et al. Phencyclidine disposition after intravenous and oral doses. Clin Pharm Therapeutics, 1982. 31(5):625–34.
Cook S. E. , Miyahara S. , Bacanu S-A. , et al. Psychotic symptoms in Alzheimer disease. Am J Geriatr Psychiatry, 2003. 11:406–13.
Coon H. , Holik J. , Hoff M. , et al. Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Med Genet, 1994. 15:72–9.
Coon H. , Myles-Worsley M. , Tiobech J. , et al. Evidence for a chromosome 2p13–14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol Psychiatry, 1998. 3:521–7.
Cooper J. E. , Kendell R. E. , Gurland B. J. , et al. (1972). Psychiatric Diagnosis in New York and London: a Comparative Study of Mental Hospital Admissions. London: Oxford.
Copolov D. , Trauer T. , Mackinnon A. On the non-significance of internal versus external auditory hallucinations. Schizophr Res, 2004. 69:1–6.
Corcoran C. , Malaspina D. Traumatic brain injury and risk for schizophrenia. Int J Ment Health, 2001. 30:17–32.
Corey L. , Whitley R. J. , Stone E. F. , Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet, 1988. 1(8575–6):1–4.
Corey-Bloom J. , Galasko D. , Hofstetter C. R. , et al. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc, 1993. 41:31–7.
Corey-Bloom J. , Jernigan T. , Archibald S. , et al. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry, 1995. 152:447–9.
Cornblatt B. A. , Erlenmeyer-Kimling L. Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. J Abnorm Psychol, 1985. 94:470–86.
Cornelius J. , et al. Characterizing organic hallucinosis. Compr Psychiatry, 1991. 32:338–44.
Correa B. B. , Xavier M. , Guimaraes J. Association of Huntington's Disease and schizophrenia-like psychosis in a Huntington's disease pedigree. Clin Pract Epidemiol Ment Health, 2006. 2:1.
Correll C. U. , Leucht S. , Kane J. M. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry, 2004. 161:414–25.
Cosway R. , et al. Sustained attention in young people at high risk for schizophrenia. Psychol Med, 2002. 32(2):277–86.
Coulter-Mackie M. B. , Gagnier L. , Beis M. J. , et al. Metachromatic leucodystrophy in three families from Nova Scotia, Canada: a recurring mutation in the arylsulphatase A gene. J Med Genet, 1997. 34:493–8.
Cowen M. , Lawrence A. The role of opioid–dopamine interactions in the induction and maintenance of ethanol consumption. Prog Neuropharmacol Biol Psychiatry, 1999. 23:1171–212.
Cox S. M. , Ludwig A. M. Neurological soft signs and psychopathology: incidence in diagnostic groups. Can J Psychiatry, 1979. 24:668–73.
Coyle J. T. , Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders [Review]. Science, 1993. 262:689–95.
Craddock N. , O'Donovan M. C. , Owen M. J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull, 2006. 32:9–16.
Craddock N. , O'Donovan M. C. , Owen M. J. Phenotypic and genetic complexity of psychosis. Invited commentary on…Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry, 2007. 190:200–3.
Craddock N. , O'Donovan M. C. , Owen M. J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet, 2005. 42:193–204.
Craddock N. , Owen M. J. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry, 2005. 186:364–6.
Craig T. J. , Richardson M. A. , Pass R. , et al. Impairment of the gag reflex in schizophrenic inpatients. Compr Psychiatry, 1983. 24:514–20.
Cramer J. A. , Rosenheck R. Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis, 1999. 187:53–5.
Cramond W. Organic Psychosis. Br Med J, 1968. 30(4):561–4.
Creese I. , Iversen S. D. Pharmacological and anatomical substrates of amphetamine response in rat. Brain Res, 1975. 83(3):419–36.
Crespo-Facorro B. , Paradiso S. , Andreasen N. C. , et al. Recalling word lists reveals “cognitive dysmetria” in schizophrenia: a positron emission tomography study. Am J Psychiatry, 1999. 156:386–92.
Crocker A. Niemann-Pick disease: A review of fifteen patients. Medicine (Baltimore), 1958. 37:1–95.
Crocq M.-A. , Mant R. , Asherson P. et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. Am J Med Genet, 1992. 29:858–60.
Crowell R. M. , Tew J. M., Jr. , Mark V. H. Aggressive dementia associated with normal pressure hydrocephalus. Report of two unusual cases. Neurology, 1973. 23(5):461–4.
Crum B. A. , Carter J. L. 26 year old man with hyperpigmentation of skin and lower extremity spasticity. Mayo Clin Proc, 1997. 72:479–82.
Crumbliss K. E. , Taussig M. J. , Jay W. M. Vision rehabilitation and Charles Bonnet Syndrome. Semin Ophthalmol, 2008. 23:121–6.
Crystal H. A. , Wolfsom L. I. , Ewing S. Visual hallucinations as the first symptom of Alzheimer's Disease. Am J Psychiatry, 1988. 145:1318.
Cubells J. F. , Feinn R. , Pearson D. , et al. Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP). Drug Alcohol Depend, 2005. 80:23–33.
Cummings J. , Miller B. Visual hallucinations: clinical occurrence and use in differential diagnosis. West Med J, 1987. 146:46–51.
Cummings J. L. , Benson D. F. (1992). Dementia: a Clinical Approach. Boston: Butterworth-Heinemann.
Cummings J. L. , Benson D. F. Subcortical dementia. Review of an emerging concept. Arch Neurol, 1984. 41(8):874–9.
Cummings J. L. , Gosenfeld L. F. , Houlihan J. P. , et al. Neuropsychiatric disturbances associated with idiopathic calcification of the basal ganglia. Biol Psychiatry, 1983. 18(5):591–601.
Cummings J. L. Frontal- subcortical circuits and human behaviour. Arch Neurol, 1993. 50:873–80.
Cummings J. L. Frontal- subcortical circuits and human behaviour. Arch Neurol, 1993. 50:873–80.
Cummings J. L. Organic delusions: phenomenology, anatomical correlations and review. Br J Psychiatry, 1985. 146:184–97.
Cummings J. L. Organic delusions: phenomenology, anatomical correlations, and review. Br J Psychiatry, 1985; 146:184–97.
Cummings J. L. Toward a molecular neuropsychiatry of neurodegenerative diseases. Ann Neurol, 2003. 54:147–54.
Cummings J. Organic delusions. Br J Psychiatry, 1985. 146:184–97.
Cummings J. Organic psychosis. Psychosomatics, 1996. 29:16–26.
Cummings J. Psychosis in neurologic disease: neurobiology and pathogenesis. Neuropsychiatr Neuropsychol Behav Neurol, 1992. 5:144–50.
Cunningham M. , Bhattacharyya S. , Benes F. Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence. J Comp Neurol, 2002. 453:116–30.
Cunningham M. O. , Hunt J. , Middleton S. , et al. Region-specific reduction in entorhinal gamma oscillations and parvalbumin- immunoreactive neurons in animal models of psychiatric illness. J Neurosci, 2006. 26(10):2767–76.
Curran C. , Byrappa N. , McBride A. Stimulant psychosis: systematic review. Br J Psychiatry, 2004. 185:196–204.
Curran C. , Byrappa N. , McBride A. Stimulant psychosis: systematic review. Br J Psychiatry, 2004. 185:196–204.
Curran H. V. , Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction, 2001. 96(5):749–60.
Curran H. V. , Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction, 2000. 95(4):575–90.
Currie S. , et al. Clinical course and prognosis of temporal lobe epilepsy. A survey of 666 patients. Brain, 1971. 94(1):173–90.
Currie S. , Heathfield K. W. G. , Henson R. A. , et al. Clinical course and prognosis of temporal lobe epilepsy. Brain, 1971. 94:173–90.
Currier G. W. , Chou J. C. , Feifel D. , et al. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. J Clin Psychiatry, 2004. 65:386–94.
Curtis D. , Kalsi G. , Brynjolfsson J. , et al. Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet, 2003. 13:77–84.
Cuthbert J. A. Wilson's disease: a new gene and an animal model for an old disease. J Investig Med, 1995. 43:323–36.
Cutting J. The phenomenology of acute organic psychosis. Comparison with acute schizophrenia. Br J Psychiatry, 1987. 151:324–32.
Cutting J. The phenomenology of acute organic psychosis. Comparison with acute schizophrenia. Br J Psychiatry, 1997. 151:324–32.
Cutting J. The phenomenology of acute organic psychosis: comparison with acute schizophrenia. Br J Psychiatry, 1987. 151:324–32.
Dürr A. , Cossee M. , Agid Y. , et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med, 1996. 335:1169–75.
D'Incerti L. MRI in neuronal ceroid lipofuscinosis. Neurol Sci, 2000. 21:S71–S3.
D'Souza D. C. , et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology, 2004. 29(8):1558–72.
D'Souza D. C. , Abi-Saab W. M. , Madonick S. , et al. Delta-9- tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry, 2005. 57:594–608.
D'Souza D. C. , Perry E. , MacDougall L. , et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology, 2004. 29:1–15.
D'Souza D. C. , Perry E. , MacDougall L. , et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology, 2004. 29:1558–72.
Dallocchio C. , Buffa C. , Tinelli C. , et al. Effectiveness of risperidone in Huntington chorea patients. J Clin Psychopharmacol, 1999. 19:101–3.
Dalman C. , Allebeck P. , Cullberg J. , et al. Obstetric complications and the risk of schizophrenia. Arch Gen Psychiatry, 1999. 56:234–40.
Dalmau A. , Bergman B. , Brismar B. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Eur Psychiatry, 1999. 14:366–71.
Daly D. Uncinate fits. Neurology, 1958. 8:250–60.
Daly M. J. , Rioux J. D. , Schaffner S. F. , et al. High-resolution haplotype structure in the human genome. Nat Genet, 2001. 29:229–32.
Damas-Mora J. , Skelton-Robinson M. , Jenner F. A. The Charles Bonnet Syndrome in perspective. Psychol Med, 1982. 12:251–61.
Dana-Haeri J. , Trimble M. R. , Oxley J. Prolactin and gonadotrophin changes following generalized and partial seizures. J Neurol Neurosurg Psychiatry, 1983. 46:331–5.
Daniel D. G. , Potkin S. G. , Reeves K. R. , et al. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology, 2001. 155:128–34.
Daniel D. G. , Zimbroff D. L. , Potkin S. G. , et al. Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group. Neuropsychopharmacology, 1999. 20:491–505.
Darian-Smith C. , Gilbert C. D. Axonal sprouting accompanies functional reorganization in adult cat striate cortex. Nature (London), 1994. 368:737–40.
Das P. , Kemp A. H. , Flynn G. , et al. Functional disconnections in the direct and indirect amygdale pathways for fear processing in schizophrenia. Schizophr Res, 2007. 90:284–94.
Das S. K. , Malhotra S. , Basu D. , et al. Testing the stress-vulnerability hypothesis in ICD-10-diagnosed acute and transient psychotic disorders. Acta Psychiatr Scand, 2001. 104:56–8.
Daskalakis Z. J. , Christensen B. K. , Chen R. , et al. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry, 2002. 59:347–54.
Davalos D. B. , Compagnon N. , Heinlein S. , et al. Neuropsychological deficits in children associated with increased familial risk for schizophrenia. Schizophr Res, 2004. 67:123–30.
David A. , Malmberg A. , Lewis G. , et al. Are there neurological and sensory risk factors for schizophrenia? Schizophr Res, 1995. 14:247–51.
David A. Auditory hallucinations: phenomenology, neuropsychology and neuroimaging update. Acta Psychiatr Scand Suppl, 1999. 395:95–104.
David A. The cognitive neuropsychiatry of auditory verbal hallucinations: an overview. Cogn Neuropsychiatry, 2004. 9:107–23.
Davids E. , Hartwig U. , Gastpar M. Antipsychotic treatment for psychosis associated with multiple sclerosis. Prog Neuropsychopharmacol Biol Psychiatry, 2004. 28:743–4.
Davies B. M. , Beech H. R. The effect of 1-arylcyclohexylamine (sernyl) on 12 normal volunteers. J Ment Sci, 1960. 106(444):912–24.
Davies D. L. Psychiatric changes associated with Friedreich's ataxia. J Neurol Neurosurg Psychiatr, 1949. 12:246–50.
Davies D. L. The intelligence of patients with Friedreich's ataxia. J Neurol Neurosurg Psychiatr, 1949. 12:34–8.
Davis F. , et al. Prevalence estimates for primary brain tumours in the United States by behaviour and major histology groups. Neuro-oncology, 2001. 3(3):152–8.
Davis K. , Stewart D. , Friedman J. , et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry, 2003. 60:443–56.
Davis K. L. , Kahn R. S. , Ko G. , et al. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry, 1991. 148:1474–86.
Davis K. L. , Stewart D. G. , Friedman J. I. , et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry, 2003. 60:443–56.
Davis L. E. , Snyder R. D. , Orth D. N. , et al. Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred. Am J Med, 1979. 66:342–7.
Davis S. M. , Lees K. R. , Albers G. W. , et al. Selfotel in acute ischemic stroke – possible neurotoxic effects of an NMDA antagonist. Stroke, 2000. 31(2):347–54.
Davison K. , Bagley C. R. (1969). Schizophrenia-like psychoses associated with organic disorder of the central nervous system; a review of the literature. In Current Problems in Neuropsychiatry. British Journal of Psychiatry Special Publication 4. Herrington R. N. (Ed.). Ashford, Kent, England: Headley Brothers, pp. 1–45.
Davison K. , Bagley C. R. (1969). Schizophrenia-like psychoses associated with organic disorders of the central nervous system. A review of the literature. In Current Problems in Neuropsychiatry, Herrington R. N. (Ed.). Ashford, Kent: Hedley, pp. 113–84.
Davison K. , Bagley C. R. (1969). Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature. In Current Problems in Neuropsychiatry. Schizophrenia, Epilepsy, the Temporal Lobe, Herrington R. N. (Ed.). Br J Psychiatry Special Publication No. 4. Ashford, Kent: Headley Brothers Ltd., pp. 113–84.
Davison K. , Bagley C. R. (1969). Schizophrenia-like psychoses associated with organic disorders of the nervous system: a review of the literature. In Current problems in neuropsychiatry, Herrington R. N. (Ed.). British Journal of Psychiatry Special Publication No 4. Ashford, Kent: Headley Brothers.
Davison K. , Bagley C. R. (1969). Schizophrenia-like psychosis associated with organic disorders of the central nervous system: a review of the literature. In Current Problems in Neuropsychiatry: Schizophrenia, Epilepsy, the Temporal Lobe. Special Publication No. 4, Herrington, R. (Ed.). London: British Psychiatric Association, pp. 1–89.
Davison K. , Bagley C. Schizophrenia-like psychosis associated with organic disorders of the central nervous system: review of the literature. Br J Psychiatry, 1969. 113(Suppl 1):18–69.
Davison K. Schizophrenia-like psychoses associated with organic cerebral lesions: a review. Psychiatr Dev, 1983. 1:1–34.
Dazzan P. , Murray R. M. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl, 2002. 43:S50–7.
De Deyn P. P. , Carrasco M. M. , Deberdt W. , et al. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease. Int J Geriatr Psychiatry, 2004. 19:115–26.
De Haan E. , Nys G. M. , van Zandvoort M. J. , Ramsey N. F. The physiological basis of visual hallucinations after damage to the primary visual cortex. Neuro Report, 2007. 18:1177–80.
De L. A. , Pasini A. , Amati F. , et al. Association study of a promoter polymorphism of UFD1L gene with schizophrenia. Am J Med Genet, 2001. 105:529–33.
De Michele G. , Disalle F. , Filla A. , et al. Magnetic resonance imaging in typical and late-onset Friedreich's disease and early onset cerebellar ataxia with retained tendon reflexes. Ital J Neurol Sci, 1995. 16:303–8.
De Mol J. , Violon A. , Brihaye J. Post-traumatic psychoses: a retrospective study of 18 cases. J Arch Psychol Neurol, 1987. 48:336–50.
de Morsier G. Le syndrome de Charles Bonnet: hallucinations visuaelles des vieillards sans deficience mentale. Ann Med Psychol (Paris), 1967. 2(5):677–702.
de Morsier G. Les automatismes visuels (Hallucinations visuelles rétro-chiasmatiques). Schweizerische Medizinische Wochenscrift, 1936. 29:700–3.
de Ronchi D. , Faranca I. , Forti P. , et al. Development of acute psychotic disorders and HIV-1 infection. Int J Psychiatry Med, 2000. 30:173–83.
De Stefano N. , Matthews P. , Arnold D. Reversible decreases in N-acetyl aspartate after acute brain injury. Mag Reson Med, 1995. 34:721–7.
Dean B. , et al. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience, 2001. 103(1):9–15.
Dean G. Annual incidence, prevalence and morbidity of multiple sclerosis in white South African-born and in white immigrants to South Africa. Br Med J, 1967. 2:724–30.
Debbane M. , Glaser B. , David M. K. , et al. (2006a) Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications. Schizophr Res, 2006a. 84:187–93.
Debbane M. , Schaer M. , Farhoumand R. , et al. Hippocampal volume reduction in 22q11.2 deletion syndrome. Neuropsychologia, 2006b. 44:2360–5.
Degenhardt L. , Copeland J. , Dillon P. Recent trends in the use of “club drugs”: an Australian review. Subst Use Misuse, 2005. 40(9–10):1241–56.
Degenhardt L. , Hall W. D. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med, 2001. 31(4):659–68.
Degenhardt L. , Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med, 2001. 31(4):659–68.
Degenhardt L. , Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med, 2001. 31:659–68.
Degenhardt L. , Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med, 2001. 31:659–68.
Degenhardt L. , Tennant C. , and Gilmour S. , et al. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: Findings from a ten-month prospective study. Psychol Med, 2007. 37(7):927–34.
Degenhardt L. D. , Hall W. Is cannabis a contributory cause of psychosis? Can J Psychiatry, 2006. 9:556–65.
Degreef G. , Ashtari M. , Bogerts B. , et al. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry, 1992. 49:531–7.
Delahunty A. , Morice R. Rehabilitation of frontal/executive impairments in schizophrenia. Aust NZ J Psychiatry, 1996. 30:760–7.
DeLisi L. E. , et al. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res, 2004. 130(1):57–70.
DeLisi L. E. , Shaw S. H. , Crow T. J. , et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry, 2002. 159:803–12.
DeLisi L. E. Is there a viral or immune dysfunction etiology to schizophrenia? Re-evaluation a decade later. Schizophr Res, 1996. 22(1):1–4.
Della Sal S. , Francescani A. , Spinnler H. Gait apraxia after bilateral supplementary motor area lesion. J Neurol Neurosurg Psychiatry, 2002. 72:77–85.
Dening T. R. , Berrios G. E. Wilson's disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry, 1990. 28:255–65.
Dening T. R. , Berrios G. E. Wilson's disease: a prospective study of psychopathology in 31 cases. Br J Psychiatry, 1989. 155:206–13.
Dening T. R. , Berrios G. E. Wilson's disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry, 1989. 46:1126–34.
DeQuardo J. R. , Keshavan M. S. , Bookstein F. L. , et al. Landmark- based morphometric analysis of first-episode schizophrenia. Biol Psychiatry, 1999. 45:1321–8.
DeRosse P. , Hodgkinson C. A. , Lencz T. , et al. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol Psychiatry, 2007. 61:1208–10.
Descheemaeker M. J. , Vogels A. , Govers V. , et al. Prader-Willi Syndrome: new insights in the behavioral and psychiatric spectrum. J Intellect Disabil Res, 2002. 46:41–50.
DeSilva C. C. , Nurse M. C. , Vokey K. Steroid-induced psychosis treated with risperidone. Can J Psychiatry, 2002. 47:388–9.
Desmukh A. , Rosenbloom M. , Pfefferbaum A. , et al. Clinical signs of cerebellar dysfunction in schizophrenia, alcoholism and their comorbidity. Schizophr Res, 2002. 57:281–91.
Desnuelle C. , Pellissier J. F. , Serratrice G. , et al. Kearns-Sayre syndrome: mitochondrial encephalomyopathy caused by deficiency of the repiratory chain. Rev Neurol, 1989. 145:842–50.
Detera-Wadleigh S. D. , Badner J. A. , et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2 . Proc Natl Acad Sci USA, 1999. 96:5604–9.
Detera-Wadleigh S. D. , McMahon F. J. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry, 2006. 60:106–14.
Detmers P. A. , La S. K. , Olsen-Egbert E. , et al. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med, 1990. 171(4):1155–62.
Detre T. , Bunney W. E. Jr. Human vibration perception. II. A preliminary report on vibration perception in psychiatric patients. Arch Gen Psychiatry, 1961. 4:615–8.
Devinsky O. , Abramson H. , Alper K. , et al. Postictal psychosis: a case control series of 20 patients and 150 controls. Epilepsy Res, 1995. 20:247–53.
Devinsky O. , Kelly K. , Porter R. J. , et al. Clinical and electroencephalographic features of simple partial seizures. Neurology, 1988. 43:1347–52.
Devlin B. , Bacanu S. A. , Roeder K. , et al. Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau. Mol Psychiatry, 2002. 7:689–94.
Devlin B. , Roeder K. , Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor Popul Biol, 2001. 60:155–66.
Dhuna A. , Toro C. , Torres F. , et al. Longitudinal neurophysiologic studies in a patient with metachromatic leukodystrophy following bone marrow transplantation. Arch Neurol, 1992. 49:1088–92.
Di Forti M. , Lappin J. , Murray R. Risk factors for schizophrenia – all roads lead to dopamine. Eur Neuropsychopharmacol, 2007. 17:S101–S107.
Diagnostic and Statistical Manual of Mental Disorder (4th Edition). (1991). Washington, DC: American Psychiatric Association.
Diamond R. , White R. F. , Myers R. H. , et al. Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol, 1992. 14:961–75.
Dichter M. A. Cellular mechanisms of epilepsy and potential new treatment strategies. Epilepsia, 1989. 30(suppl 1):S3–S12.
Diefendorf A. , Dodge R. An experimental study of the ocular reactions of the insane from photographic records. Brain, 1908. 31:451–89.
Dierks T. , Linden D. E. , Jandl M. , et al. Activation of Heschl's gyrus during auditory hallucinations. Neuron, 1999. 22:615–21.
Dietemann J. , Flippi de la Palavesa M. , Tranchant C. , et al. MR findings in mannosidosis. Neuroradiology, 1990. 33:485–7.
DiGirolamo G. , Posner M. Attention and schizophrenia: a view from cognitive neuroscience. Cogn Neuropsychiatry, 1996. 1:95–102.
Dikeos D. G. , Wickham H. , McDonald C. , et al. Distribution of symptom dimensions across Kraepelinian divisions. Br J Psychiatry, 2006. 189:346–53.
Dillon P. , Copeland J. , Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend, 2003. 69(1):23–8.
DiMauro S. E. B. (2003). Mitochondrial disorders due to mutations in the mitochondrial genome. In The Molecular and Genetic Basis of Neurologic and Psychiatric Disease, Rosenberg R. N. , Prusiner S. B. , and DiMauro S. , et al. (Eds.). Philadelphia: Butterworth Heinemann.
Diwadkar V. A. , et al. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry, 2006. 30(2):230–8.
Dixon L. , et al. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull, 1990. 16(1):69–79.
Dolder C. R. , Patterson T. L. , Jeste D. V. HIV, psychosis and aging: past, present and future. AIDS, 2004. 18(Suppl 1):S35–4.
Dom G. , Sabbe B. , Hulstijn W. , van den Brink W. Substance use disorders and the orbitofrontal cortex. Br J Psychiat, 2005. 187:209–20.
Domenech E. , Gomez-Zaera M. , Nunes V. Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease. Pediatr Endocrinol Rev, 2006. 3(3):249–57.
Domino E. F. , Chodoff P. , Corssen G. Pharmacologic effects of Cl-581 a new dissociative anesthetic in man. Clin Pharmacol Therapeutics, 1965. 6(3):279–90
Domino E. F. , Luby E. D. (1981). Abnormal mental states induced by phencyclidine as a model of schizophrenia. In PCP (Phencyclidine): Historical and Current Perspectives, Domino E. F. (Ed.). Ann Arbor, Michigan: NPP Books, pp. 401–19.
Donald M. , Dower J. , Kavanagh D. J. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: A qualitative systematic review of randomised controlled trials. Soc Sci Med, 2005. 60:1371–83.
Donnet A. , Habib M. , Pellissier J. , et al. Kuf's disease presenting as progressive dementia with late-onset generalized seizures: a clinicopathological and electrophysiological study. Epilepsia, 1992. 33:65–74.
Donohue G. Adherence to antipsychotic treatment in schizophrenia: what role does cognitive behavioral therapy play in improving outcomes? Dis Manage Health Outcomes, 2006. 14:207–14.
Dopke C. A. , Lehner R. K. , Wells A. M. Cognitive-behavioral group therapy for insomnia in individuals with serious mental illnesses: a preliminary evaluation. Psychiatr Rehabil J, 2004. 27:235–42.
Dotson J. W. , Ackerman D. L. , West L. J. Ketamine abuse. J Drug Issues, 1995. 25(4):751–7.
Dotti M. , Federico A. , Signorini E. , et al. Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings. AJNR Am J Neuroradiol, 1994. 15:1721–6.
Dotti M. , Salen G. , Federico A. Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing. Dev Neurosci, 1991. 13:371–6.
Douen A. G. , Bourque P. R. Musical auditory hallucinosis from Listeria rhombencephalitis. Can J Neurol Sci, 1997. 24(1):70–2.
Douki S. , Taktak M. J. , Ben Zineb S. , et al. Therapeutic strategies in the first psychotic episode. Encephale, 1999. 25 Spec No 3:44–51.
Downing J. The psychological and physiological effects of MDMA on normal volunteers. J Psychoactive Drugs, 1986. 18:335–40.
Downing P. E. , Jiang Y. H. , Shuman M. , et al. A cortical area selective for visual processing of the human body. Science (Washington, DC), 2001. 293:2470–3.
Doyle M. E. , Labbate L. A. Incidence of HIV infection among patients with new-onset psychosis. Psychiatr Serv, 1997. 48:237–8.
Drachman D. A. , O'Donnell B. F. , Swearer J. M. The prognosis in Alzheimer's disease: how far rather than how fast best predicts the course. Arch Neurol, 1990. 47:851–6.
Drake R. E. , Bartels S. B. , Teague G. B. , et al. Treatment of substance abuse in severely mentally ill patients. J Nerv Ment Dis, 1993. 181:606–11.
Drake R. E. , Gates C. , Cotton P. G. , Whitaker A. Suicide among schizophrenics. Who is at risk? J Nerv Ment Dis, 1984. 172:613–17.
Drake R. E. , McHugo G. J. , Clark R. E. , et al. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: A clinical trial. Am J Orthopsychiatry, 1998. 68:201–15.
Drake R. E. , Mercer-McFadden C. , Mueser K. T. , et al. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull, 1998. 24:589–608.
Drake R. E. , Mueser K. T. , Brunette M. F. , et al. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatr Rehabil J, 2004. 27:360–74.
Drake R. E. , O'Neal E. A systematic review of research on interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat, in press.
Drake R. E. , Wallach M. A. , McGovern M. P. Future directions in preventing relapse to substance abuse among clients with severe mental illnesses. Psychiatr Serv, 2005. 56:1297–302.
Drake R. E. , Wallach M. Moderate drinking among people with severe mental illness. Hosp Community Psychiatry, 1993. 44:780–2.
Drake R. E. , Wallach W. A. , Alverson H. S. , et al. Psychosocial aspects of substance abuse by clients with severe mental illness. J Nerv Ment Dis, 2002. 190:100–6.
Drebing C. E. , Van Ormer E. A. , Krebs C. The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans. J Appl Behav Anal, 2005. 38:359–72.
Drevets W. Rubin E. H. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry, 1989. 25:39–48.
Driessen M. , et al. Proposal of a comprehensive clinical typology of alcohol withdrawal – a cluster analysis approach. Alcohol, 2005. 40:308–13.
Drugs that cause psychiatric symptoms. Med Lett Drugs Ther, 1993. 35:65–70.
Drugs that may cause psychiatric symptoms. Med Lett Drugs Ther, 2002. 44:59–62.
Dubois B. , et al. Cholinergic dependent cognitive deficits in Parkinson's disease. Ann Neurol., 1987. 22:26–30.
Dubois M. J. , Bergeron N. , Dumont M. , et al. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med, 2001. 27:1297–1304.
Duckett S. , Galle P. , Escourolle R. , et al. Presence of zinc, aluminum, magnesium in striopalledodentate (SPD) calcifications (Fahr's disease): electron probe study. Acta Neuropathol, 1977. 38(1):7–10.
Dudbridge F. , Koeleman B. P. Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. Am J Hum Genet, 2004. 75:424–35.
Duerr R. H. , Taylor K. D. , Brant S. R. , et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science, 2006. 314:1461–3.
Dukes C. S. , Luft B. J. , Durak D. T. (1997). Toxoplasmosis. In Infections of the Central Nervous System, Scheld W. M. , Whitley R. J. , and Durack D. T. (Eds). Philadelphia: Lippincott-Raven, pp. 785–806.
Duncan E. J. , Madonick S. H. , Parwani A. , et al. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology, 2001. 25(1):72–83.
Duncan G. E. , Leipzig J. N. , Mailman R. B. , et al. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Res, 1998. 812(1–2):65–75.
Duncan G. E. , Miyamoto S. , Leipzig J. N. , et al. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res, 1999. 843(1–2):171–83.
Duncan G. E. , Moy S. S. , Knapp D. J. , et al. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res, 1998. 787(2):181–90.
Dupre E. Les cenestipathies. Mouvement Medical, 1913. 23:3–22.
Dursun S. M. , Deakin J. F.W. Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case series outcome study. J Psychopharmacol, 2001. 15(4):297–301.
Dursun S. M. , McIntosh D. Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry, 1999. 56(10):950.
Dutton J. L. , Poronnik P. , Li G. H. , et al. P2X1 receptor membrane redistribution and down-regulation visualized by using receptor-coupled green fluorescent protein chimeras. Neuropharmacology, 2000. 39:2054–66.
Duyao M. , Ambrose C. , Myers R. , et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet, 1993. 4:387–92.
Duyao M. P. , Auerbach A. B. , Ryan A. , et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science, 1995. 269: 407–10.
Duyff R. F. , Weinstein H. C. Late-presenting metachromatic leukodystrophy. Lancet, 1996. 348:1382–3.
Dyer J. , Roth B. , Hyma B. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med, 2001. 37:147–53.
Dykens E. M. , Cassidy S. B. Correlates of maladaptive behavior in children and adults with Prader-Willi syndrome. Neuropsychiatric Genetics, 1995. 60:546–9.
Eaton W. W. , Romanoski A. , Anthony J. C. , Nestadt G. Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis, 1991. 179: 689–93.
Eaton W. W. Epidemiology of schizophrenia. Epidemiol Rev, 1985. 7:105–26.
Ebersbach G. An artist's view of drug-induced hallucinosis. Mov Disord, 2003. 18:833–4.
Ebmeier K. P. , Lawrie S. M. , Blackwood D. H. R. , et al. Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia. J Neurosurg Psychiatry, 1995. 58:452–6.
Echlin F. A. , Arnett V. , Zoll J. Paroxysmal high voltage discharges from isolated and partially isolated human and animal cerebral cortex. EEG Clin Neurophysiol, 1952. 4:147–64.
Edwards J. , Elkins K. , Hinton M. , et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand, 2006. 114:109–17.
Edwards-Lee T. , Cummings J. (2000). Focal lesions and psychosis, In Behaviour and Mood Disorders in Focal Brain Lesions, Bogovsslavsky J. and Cummings J. (Eds.). Cambridge: Cambridge University Press, pp. 419–36.
Edwards-Lee T. , Miller B. L. , Benson D. F. , et al. The temporal variant of frontotemporal dementia. Brain, 1997. 120:1027–40.
Egan M. F. , Goldberg T. E. , Kolachana B. S. , et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA, 2001. 98:6917–22.
Eggermont J. J. , Roberts L. E. The neuroscience of tinnitus. Trends Neurosci, 2004. 27(11):676–82.
Eichenbaum H. Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron, 2004. 44(1):109–20.
Einfeld S. L. , Piccinin A. M. , Mackinnon A. , et al. Psychopathology in young people with intellectual disability. JAMA, 2006. 296:1981–9.
Einfeld S. L. , Smith A. , Durvasula S. , et al. Behavior and emotional disturbance in Prader-Willi Syndrome. Am J Med Genet A, 1999. 82:123–7.
Einfeld S. L. Behaviour phenotypes of genetic disorders. Curr Opin Psychiatry, 2004. 17:343–8.
Ekelund J. , Hennah W. , Hiekkalinna T. , et al. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol Psychiatry, 2004. 9:1037–41.
Ekelund J. , Hovatta I. , Parker A. , et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet, 2001. 10:1611–17.
Ekelund J. , Lichtermann D. , Hovatta I. , et al. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet, 2000. 9:1049–57.
El-Husseini A. E. , Craven S. E. , Chetkovich D. M. , et al. Dual palmitoylation of PSD-95 mediates its vesiculotubular sorting, postsynaptic targeting, and ion channel clustering. J Cell Biol, 2000. 148:159–72.
El-Youssef M. Wilson's disease. Mayo Clin Proc. 2003. 78:1126–36.
Eleopra R. , Accurti I. , Neri W. , et al. Unusual case of Fahr syndrome with motoneuron disease. Ital J Neurol Sci, 1991. 12(6):597–600.
Elie M. , Cole M. G. , Primeau F. J. , et al. Delirium risk factors in elderly hospitalised patients. J Gen Intern Med, 1998. 13:204–12.
Eliez S. , Barnea-Goraly N. , Schmitt J. E. , et al. Increased basal ganglia volumes in velo-cardio-facial syndrome (deletion 22q11.2). Biol Psychiatry, 2002. 52:68–70.
Eliez S. , Blasey C. M. , Schmitt E. J. , et al. Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia? Am J Psychiatry, 2001. 158:447–53.
Eliez S. , Schmitt J. E. , White C. D. , et al. Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry, 2000. 157:409–15.
Elleder M. , Jirasek A. , Smid F. , et al. Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol, 1985. 66:325–66.
Ellie E. , Julien J. , Ferrer X. Familial idiopathic striopallidodentate calcifications. Neurology, 1989. 39(3):381–5.
Ellinwood E. H. , Jr . Amphetamine psychosis: I. Description of the individuals and process. J Nervous Mental Disease, 1967. 144:273–83.
Ellis T. , Cudkowicz M. E. , Sexton P. M. , et al. Clozapine and risperidone treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci, 2000. 12:364–9.
Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula. Brain Res Brain Res Rev, 1994. 19(2):223–39.
Elrington G. M. , Bateman D. E. , Jeffrey M. J. , et al. Adrenoleukodystrophy: heterogeneity in two brothers. J Neurol Neurosurg Psychiatry, 1989. 52:310–13.
Emamian E. S. , Hall D. , Birnbaum M. J. , et al. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet, 2004. 36:131–7.
Engel A. K. , Moll C. K. E. , Fried I. , et al. Invasive recordings from the human brain: clinical insights and beyond. Nat Rev Neurosci, 2005. 6:35–47.
Engel J. Jr . Excitation and inhibition in epilepsy. Can J Neurol Sci, 1996. 23:167–74.
Engel J. Jr. , Bandler R. , Griffith N. C. , et al. (1991). Neurobiological evidence for epilepsy-induced interictal disturbances. In Neurobehavioral Problems in Epilepsy: Advances in Neurology, vol. 55. Smith D. , Treiman D. , and Trimble M. (Eds.). New York: Raven Press, pp. 97–111.
Engel J. Jr. , Caldecott-Hazard S. , Bandler R. Neurobiology of behavior: anatomic and physiologic implications related to epilepsy. Epilepsia, 1986; 27(suppl2):S3–S13.
Epping-Jordan M. P. , Markou A. , Koob G. F. The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat. Brain Res, 1998. 784:105–15.
Epstein J. N. , et al. The effects of anxiety on continuous performance test functioning in an ADHD clinic sample. J Atten Disord, 1997. 2(1):45–52.
Epstein R. , Kanwisher N. A cortical representation of the local visual environment. Nature (London), 1998. 392:598–601.
Erard R. , Luisada P. V. , Peele R. The PCP psychosis – prolonged intoxication or drug-precipitated functional illness. J Psychedelic Drugs, 1980. 12(3–4):235–51.
Erkwoh R. , Sabri O. , Willmes K. , et al. Aspects of cerebral connectivity in schizophrenia. A comparative CBF study on treated schizophrenics before and after medication. Fortschr Neurol Psychiatr, 1999. 67:318–26.
Erlenmeyer-Kimling L. , et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry, 2000. 157(9):1416–22.
Erlenmeyer-Kimling L. , et al. The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up. Arch Gen Psychiatry, 1995. 52(10):857–65.
Eror E. A. , Lopez O. L. , Dekosky S. T. , et al. Alzheimer Disease subjects with psychosis have increased schizotypal symptoms before dementia onset. Biol Psychiatry, 2005. 58:325–30.
Erritzoe D. , et al. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia. Neuroimaging Clin N Am, 2003. 13(4):817–32.
Escolar M. L. , Poe M. D. , Provenzsale J. M. , et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Eng J Med, 2005. 352:2069–81.
Essock S. M. , Mueser K. T. , Drake R. E. , et al. Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatr Serv, 2006. 57:185–96.
Everett C. M. , Wood N. W. Trinucleotide repeats and neurodegenerative disease. Brain, 2004. 127:2385–405.
Evers-Kiebooms G. , Nys K. , Harper P. , et al. Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative study. Eur J Hum Genet, 2002. 10:167–76.
Ey H. (1954). ‘Bouffees delirantes’ et psychoses hallucinatories aigus. etudes psychiatriques. Vol 3. Paris: Desclee de Brouwer, pp. 203–324.
Eysel U. , et al. Reorganization in the visual cortex after retinal and cortical damage. Restor Neurol Neurosci, 1999. 15:153–64.
Ezaki J. , Kominami E. The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Brain Pathol, 2004. 14:77–85.
Förstl H. , Almeida O. P. , Owen A. M. , et al. Psychiatric, neurological and medical aspects of misidentification syndromes: a review of 260 cases. Psychol Med, 1991. 21:905–10.
Förstl H. , Burns A. , Levy R. , et al. Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's Disease. Br J Psychiatry, 1994. 165:53–9.
Faber K. M. , Johnson L. N. Hallucinating the past: a case of spontaneous and involuntary recall of long-term memories. Perspectives on the hemispheric organization of visual memory. J Neurol, 2003. 250:55–62.
Faber N. B. , Rubin E. H. , Newcomer J. W. , et al. Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Arch Gen Psychiatry, 2000. 57:1165–73.
Factor S. A. , Friedman J. H. The emerging role of clozapine in the treatment of movement disorders. Mov Disord, 1997. 12:483–96.
Factor S. A. , Molho E. S. Emergency department presentations of patients with Parkinson's disease. Am J Emerg Med, 2000. 18:209–15.
Faingold C. , Gouemo P. N. , Riaz A. Ethanol and neurotransmitter interactions – from molecular to integrative effects. Prog Neurobiol, 1998. 55:509–35.
Falck R. S. , Carlson R. G. , Wang J. C. , et al. Psychiatric disorders and their correlates among young adult MDMA users in Ohio. J Psychoactive Drugs, 2006. 38(1):19–29.
Fallgatter A. J. , Strik W. K. Reduced frontal functional asymmetry in schizophrenia during a cued continuous performance test assessed with near-infrared spectroscopy. Schizophr Bull, 2000. 26:913–19.
Fallin M. D. , Lasseter V. K. , Wolyniec P. S. , et al. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet, 2003. 73:601–11.
Fan Q.-W. , Yu W. , Gong J-S. , et al. Cholesterol-dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons. J Neurochem, 2002. 80:178–90.
Fann J. R. , Burington B. , Leonetti A. , et al. Psychiatric illness following traumatic brain injury in a adult health maintenance organization population. Arch Gen Psychiatry, 2004. 61:53–61.
Fann J. R. , Roth-Roemer S. , Burington B. E. , et al. Delirium in patients undergoing haematopoietic stem cell transplantation. Cancer, 2002. 95:1971–81.
Faraone S. V. , Hwu H. G. , Liu C. M. , et al. Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3 . Am J Psychiatry, 2006. 163:1760–6.
Faraone S. V. , Matise T. , Svrakic D. , et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet, 1998. 81:290–5.
Farber N. B. , Wozniak D. F. , Price M. T. , et al. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatr, 1995. 38(12):788–96.
Farber R. S. , Kerrigan J. R. The multiple indications for growth hormone treatment of pediatric patients. Pediatric Annals, 2006. 35:926–32.
Faria A. V. , Pereira I. C. , Nanni L. Computerized tomography findings in Fahr's syndrome. Arq neuropsiquiatr, 2004. 62(3B):789–92.
Farkas T. , Wolf A. P. , Jaeger J. , et al. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Arch Gen Psychiatry, 1984. 41:293–300.
Farooq S. , Khawaja M. Y. Fever and acute brief psychosis in developing countries. Br J Psychiatry, 1999. 175:586.
Farrell D. F. , Hamilton S. R. , Krauss T. A. , et al. X-linked adrenoleukodystrophy: adult cerebral variant. Neurology, 1993. 43:1518–22.
Farrell M. , Boys A. , Bebbington P. , et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry, 2002. 181:393–8.
Farrell M. , Boys A. , Bebbington P. , et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry, 2002. 181:393–8.
Fatemi S. H. , Emamian E. S. , Kist D. , et al. Defective corticogenesis and reduction in reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry, 1999. 4(2):145–54.
Fattal O. , Budur K. , Vaughan A. J. , et al. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics, 2006. 47(1):1–7.
Fattal O. , Budur K. , Vaughan A. J. , et al. Review of the Literature on Major Mental Disorders in Adult Patients with Mitochondrial Diseases. Psychosomatics, 2006. 47:1–7.
Fauman B. , Baker F. , Coppleson L. W. , et al. Psychosis induced by phencyclidine. Concepts, Comp and Config, 1975. 4(3):223–5.
Fauman M. A. , Fauman B. (1978). The psychiatric aspects of chronic phencyclidine use: a study of chronic PCP users. In Phencyclidine (PCP) Abuse: An Appraisal, vol Monograph 21, Petersen R. C. and Stillman R. C. (Eds.). Rockville, Maryland: National Institute on Drug Abuse, pp. 183–200.
Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatric Clin N Am, 1997. 20:427–51.
FDA Drug Bulletin: Ketamine abuse. FDA Drug Bulletin, 1979. 9(4):24.
Federico A. , Palmeri S. , Malandrini A. The clinical aspects of adult hexosaminidase deficiencies. Dev Neurosci, 1991. 13:280–7.
Fein G. , Biggins C. , MacKay S. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiatry, 1996. 39(11):955–65.
Feinberg A. P. Phenotypic plasticity and the epigenetics of human disease. Nature, 2007. 447:433–40.
Feinberg F. The problems of anticholinergic effects in older patients. Drugs Ageing, 1993. 3:335–48.
Feinberg I. , Guazzelli M. Schizophrenia – a disorder of the corollary discharge systems that integrate the motor systems of thought with the sensory systems of consciousness. Br J Psychiatry, 1999. 174:196–204.
Feinberg I. Schizophrenia and late maturational brain changes in man. Psychopharmacol Bull, 1982. 18:29–31.
Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res, 1982. 17:319–34.
Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res, 1982. 17:319–34.
Feinstein A. , du Boulay G. , Ron M. A. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. (See comment.) Br J Psychiatry, 1992. 161:680–5.
Feinstein A. , du Boulay G. , Ron M. A. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry, 1992. 161:680–5.
Feinstein A. , Ron M. A. Psychosis associated with demonstrable brain disease. Psychol Med, 1990. 20:793–803.
Feinstein A. , Ron M. A. Psychosis associated with demonstrable brain disease. Psychol Med, 1990. 20:793–803.
Feinstein A. , Ron M. Psychosis associated with demonstrable brain disease. Psychiatr Med, 1990. 20:793–803.
Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry, 2004. 49:157–63.
Feinstein C. , Eliez S. , Blasey C. , et al. Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry, 2002. 51:312–18.
Felice K. J. , Lira G. M. , Natowicz M. Adult onset metachromatic leukodystrophy: a gene mutation with isolated polyneuropathy. Neurology, 2000. 55:1036–9.
Fendri C. , Mechri A. , Khiari G. , et al. Oxidative stress involvement in schizophrenia pathophysiology: a review. Encephale, 2006. 32(2 Pt 1):244–52.
Fenelon G. , et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain, 2000. 123:733–45.
Fenelon G. , et al. Tactile hallucinations in Parkinson's disease. J Neurol, 2002. 249:1699–703.
Fenelon G. , Gray F. , Paillard F. , et al. A prospective study of patients with CT detected pallidal calcifications. J Neurol Neurosurg Psychiatry, 1993. 56(6):622–5.
Fennig S. , Bromet E. J. , Craig T. , et al. Psychotic patients with unclear diagnoses. A descriptive analysis. J Nerv Ment Dis, 1995. 183:207–13.
Fenton G. W. Epilepsy and automatism. Br J Hosp Med, 1972. 7:57–64.
Fenton W. S. , Blyler C. R. , Wyatt R. J. , et al. Prevalence of spontaneous dyskinesia in schizophrenic and nonschizophrenic psychiatric patients. Br J Psychiatry, 1997. 171:265–8.
Fenwick P. (1990). The use of magnetocencephalography in neurology. In Advances in Neurology, vol 54: Magnetoencephalography. Sato S. (Ed.). New York: Raven Press, pp. 271–82.
Ferdinand R. F. , Sondeijker F. , Van Der Ende J. , et al. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction, 2005. 100:612–18.
Fergusson D. , Horwood J. , Swain-Campbell N. Cannabis dependence and psychotic symptoms in young people. Psychol Med, 2003. 33(1):15–21.
Fergusson D. M. , Horwood L. J. , Ridder E. M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction, 2005. 100(3):354–66.
Fergusson D. M. , Horwood L. J. , Ridder E. M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction, 2005. 100:354–66.
Fernandes L. H. S. , Scassellati-Sforzolin B. , Spaide R. F. Estrogen and visual hallucinations in a patient with Charles Bonnet syndrome. Am J Ophthalmol, 2000. 129:407.
Fernandez A. , Lichtshein G. , Vieweg V. R. W. The Charles Bonnet Syndrome: a review. J Nerv Ment Dis, 1997. 185(3):195–200.
Fernandez H. H. , Friedman J. H. , Jacques C. , et al. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord, 1999. 14:484–7.
Fernandez H. H. , Trieschmann M. E. , Burke M. A. , et al. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Mov Disord, 2003. 18:510–14.
Fernandez H. H. , Trieschmann M. E. , Burke M. A. , et al. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. J Clin Psychiatry, 2002. 63:513–15.
Fernandez-Bouzas A. , Angrist B. , Hemdal P. , et al. Basal ganglia calcification in schizophrenia. Biol Psychiatry, 1990. 27(6):682–5.
Ferraro A. Familiar form of encephalitis periaxialis diffusa. J Nerv Ment Dis, 1927. 66:329–54.
Ferraro A. Pathological changes in the brain of a case clinically diagnosed dementia praecox. J Neuropath Exp Neurol, 1943. 2:84–94.
Feuk L. , Marshall C. R. , Wintle R. F. , et al. Structural variants: changing the landscape of chromosomes and design of disease studies. Hum Mol Genet, 2006. 15 Spec No 1:R57–66.
Ffischer C. , Ellger T. The clinical spectrum of musical hallucinations. J Neurol Sci, 2004. 227(1):55–65.
Ffischer C. , Marchie A. , Norris M. Musical and auditory hallucinations: a spectrum. Psychiatry Clin Neurosci, 2004. 58(1):96–8.
Ffytche D. , et al. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nature Neurosci, 1998. 1:738–42.
Ffytche D. , Howard R. The perceptual consequences of visual loss: ‘positive’ pathologies of vision. Brain, 1999. 122:1247–60.
Ffytche D. H. , Catani M. Beyond localization: from hodology to function. Phil Trans R Soc B, 2005. 360:767–79.
Ffytche D. H. , Howard R. J. , Brammer M. J. , et al. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci, 1998. 1:738–42.
Ffytche D. H. , Howard R. J. The perceptual consequences of visual loss: ‘positive’ pathologies of vision. Brain, 1999. 122:1247–60.
Ffytche D. H. , Lappin J. M. , Philpot M. Visual command hallucinations in a patient with pure alexia. J Neurol Neurosurg Psychiatry, 2004. 75:80–6.
Ffytche D. H. , Lappin J. M. , Philpot M. Visual command hallucinations in a patient with pure alexia. J Neurol Neurosurg Psychiatry, 2004. 75:80–6.
Ffytche D. H. The hodology of hallucinations. Cortex, 2008. 44(8):1067–83.
Ffytche D. H. Two visual hallucinatory syndromes. Behav Brain Sci, 2005. 28(6):763–4.
Ffytche D. H. Visual hallucinations in eye disease. Curr Opin Neurol, 2009. 22:28–35.
Ffytche D. Visual hallucination and illusion disorders: a clinical guide. Adv Clin Neurosci Rehabil, 2004. 4:16–18.
Filley C. M. , Thompson L. L. , Sze C. I. , et al. White matter dementia in CADASIL. J Neurol Sci, 1999. 163:163–7.
Finelli P. F. Metachromatic leukodystrophy manifesting as a schizophrenic disorder: computed tomographic correlation. Ann Neurol, 1985. 18:94–5.
Fink J. , Filling-Katz M. , Sokal J. Clinical spectrum of Niemann-Pick disease type C. Neurology, 1989. 39:1040–9.
Fink M. , Green M. , Bender M. B. The face–hand test as a diagnostic sign of organic mental syndrome. Neurology, 1952. 2:46–58.
Fink M. , Simeon J. , Haque W. , et al. Prolonged adverse reactions to LSD in psychotic subjects. Arch Gen Psychiatry, 1966. 15(5):450.
Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand, 2006. 114:217–38.
Fischer K. M. Expanded (CAG)n, (CGG)n and (GAA)n trinucleotide repeat microsatellite, and mutant purine synthesis and pigmentation genes cause schizophrenia and autism. Med Hypoth, 1998. 51:223–33.
Fisher R. S. , Prince D. A. Spike-wave rhythms in cat cortex induced by parenteral penicillin. II. Cellular features. Electroencephalogr Clin Neurophysiol, 1977. 42:625–39.
Fisher R. S. , Schachter S. C. The postictal state: a neglected entity in the management of epilepsy. Epilepsy Behav, 2000. 1:52–9.
Fitzgerald R. G. Visual phenomenology in recently blind adults. Am J Psychiatry, 1971. 127:1533–9.
Flacker J. , Lipsitz L. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol, 1999. 54:8239–46.
Flacker J. M. , Lipsitz L. A. Neural mechanisms of delirium: current hypotheses are evolving concepts. J Gerontol A Biol Sci Med, 1999. 54:B239–46.
Flashman L. A. , Flaum M. , Gupta S. , et al. Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry, 1996. 153:526–32.
Flaum M. , Schultz S. When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry, 1996. 153:812–15.
Flaum M. , Schultz S.K. When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry, 1996. 153(6):812–5.
Fleminger S. Delusional misidentification: an exemplary symptom illustrating an interaction between organic brain disease and psychological processes. Psychopathology, 1994. 27:161–7.
Fletcher P. , et al. Abnormal cingulate modulation of fronto-temporal connectivity in schizophrenia. Neuroimage, 1999. 9(3):337–42.
Fletcher P. C. , Honey G. D. Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits. Trends a Cogn Sci, 2006. 10(4):167–74.
Flint J. , Goldstein L. H. Familial calcification of the basal ganglia: a case report and review of the literature. Psychol Med, 1992. 22(3):581–95.
Flor-Henry P. Psychosis and temporal lobe epilepsy. Epilepsia, 1969. 10:363–95.
Florence S. L. , Taub H. B. , Kaas J. H. Large-scale sprouting of cortical connections after peripheral injury in adult macaque monkeys. Science (Washington, DC), 1998. 282:1117–21.
Floyd A. G. , Boutros N. N. , Struve F. A. , Wolf E. , Oliwa G. M. Risk factors for experiencing psychosis during cocaine use: a preliminary report. J Psychiatr Res, 2006. 40(2):178–82. [Epub Jul 26, 2005.]
Floyd A. G. , Boutros N. N. , Struve F. A. , Wolf E. , Oliwa G. M. Risk factors for experiencing psychosis during cocaine use: a preliminary report. J Psychiatr Res, 2006. 40:178–82.
Flyckt L. , Sydow O. , Bjerkenstedt L. , et al. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res, 1999. 86:113–29.
Foerster O. The cerebral cortex in man. Lancet, 1931. 2:309–19.
Fogel B. L. , Perlman S. Clinical features and molecular genetics of autosomal cerebellar ataxias. Lancet neurol, 2007. 6:245–57.
Foley J. Calcification of the corpus stiatum and dentate nuclei occurring in a family. J Neurol Neurosurg Psychiatry, 1951. 14(4):253–61.
Folstein S. E. , Abbott M. H. , Chase G. A. , et al. The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med, 1983. 13:537–42.
Folstein S. E. , Chase G. , Wahl W. E. , et al. Huntington's disease in Maryland: clinical aspects of racial variation. Am J Hum Genet, 1987. 41:168–79.
Folstein S. E. , Chase G. A. , Wahl W. E. , et al. Huntington disease in Maryland: clinical aspects of racial variation. Am J Hum Genet, 1987. 41:168–79.
Fong G. C. , Fong K. Y. , Mak W. , et al. Postictal psychosis related regional cerebral hyperperfusion. J Neurol Neurosurg Psychiatry, 2000. 68:100–1.
Fontaine C. S. , Hynan L. S. , Koch K. , et al. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. J Clin Psychiatry, 2003. 64:726–30.
Fontaine C. S. , Hynan L. S. , Koch K. , et al. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities. J Clin Psychiatry, 2003. 64:726–30.
Ford J. M. , Mathalon D. H. Electrophysiological evidence of corollary discharge dysfunction in schizophrenia during talking and thinking. J Psychiatr Res, 2004. 38:37–46.
Ford J. M. , Roach B. J. , Faustman W. O. , et al. Out-of-synch and out-of-sorts: dysfunction of motor-sensory communication in schizophrenia. Biol Psychiatry, 2008. 63:736–43.
Forman M. S. Genotype-phenotype correlations in FTDP-17: does form follow function? Exp Neurol, 2004. 187:229–34.
Foroud T. , Siemers E. , Kleindorfer D. , et al. Cognitive scores of carriers of Huntingont's disease gene compared to non-carriers. Ann Neurol, 1995. 37:657–64.
Forrer G. Benign auditory and visual hallucinations. Arch Gen Psychiatry, 1964. 3:95–8.